JP6645971B2 - Fluorine-containing hyperbranched polymer and biomolecule adsorption suppressing surface - Google Patents
Fluorine-containing hyperbranched polymer and biomolecule adsorption suppressing surface Download PDFInfo
- Publication number
- JP6645971B2 JP6645971B2 JP2016546680A JP2016546680A JP6645971B2 JP 6645971 B2 JP6645971 B2 JP 6645971B2 JP 2016546680 A JP2016546680 A JP 2016546680A JP 2016546680 A JP2016546680 A JP 2016546680A JP 6645971 B2 JP6645971 B2 JP 6645971B2
- Authority
- JP
- Japan
- Prior art keywords
- hyperbranched polymer
- fluorine
- group
- film
- monomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920000587 hyperbranched polymer Polymers 0.000 title claims description 172
- 229910052731 fluorine Inorganic materials 0.000 title claims description 94
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 title claims description 91
- 239000011737 fluorine Substances 0.000 title claims description 91
- 238000001179 sorption measurement Methods 0.000 title claims description 43
- 239000010408 film Substances 0.000 claims description 124
- 239000000203 mixture Substances 0.000 claims description 102
- -1 acryl group Chemical group 0.000 claims description 64
- 239000000178 monomer Substances 0.000 claims description 55
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 48
- 239000002904 solvent Substances 0.000 claims description 44
- 150000001875 compounds Chemical class 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 36
- 229920000642 polymer Polymers 0.000 claims description 35
- 238000004519 manufacturing process Methods 0.000 claims description 32
- 229920005989 resin Polymers 0.000 claims description 32
- 239000011347 resin Substances 0.000 claims description 32
- 238000000576 coating method Methods 0.000 claims description 26
- 239000003505 polymerization initiator Substances 0.000 claims description 26
- 239000000758 substrate Substances 0.000 claims description 18
- 125000005702 oxyalkylene group Chemical group 0.000 claims description 17
- 239000011248 coating agent Substances 0.000 claims description 16
- 239000002966 varnish Substances 0.000 claims description 15
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims description 14
- 239000010409 thin film Substances 0.000 claims description 12
- 230000000379 polymerizing effect Effects 0.000 claims description 11
- 238000004528 spin coating Methods 0.000 claims description 11
- 229920005992 thermoplastic resin Polymers 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 10
- 125000003709 fluoroalkyl group Chemical group 0.000 claims description 10
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 125000002947 alkylene group Chemical group 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 5
- 230000001629 suppression Effects 0.000 claims description 5
- KAKZBPTYRLMSJV-UHFFFAOYSA-N vinyl-ethylene Natural products C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 70
- 239000004926 polymethyl methacrylate Substances 0.000 description 70
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 59
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 52
- 239000012528 membrane Substances 0.000 description 47
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- 239000000243 solution Substances 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 23
- 238000010438 heat treatment Methods 0.000 description 23
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 18
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 18
- 239000002953 phosphate buffered saline Substances 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 17
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 17
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 15
- 229940098773 bovine serum albumin Drugs 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 15
- 102000004169 proteins and genes Human genes 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 13
- BGRWYRAHAFMIBJ-UHFFFAOYSA-N 1,3-di(propan-2-yl)urea Chemical compound CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 12
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 12
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 12
- 238000010586 diagram Methods 0.000 description 12
- 238000002329 infrared spectrum Methods 0.000 description 12
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
- 229920002554 vinyl polymer Polymers 0.000 description 10
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 238000006116 polymerization reaction Methods 0.000 description 9
- 239000010703 silicon Substances 0.000 description 9
- VFXXTYGQYWRHJP-UHFFFAOYSA-N 4,4'-azobis(4-cyanopentanoic acid) Chemical compound OC(=O)CCC(C)(C#N)N=NC(C)(CCC(O)=O)C#N VFXXTYGQYWRHJP-UHFFFAOYSA-N 0.000 description 8
- 238000000137 annealing Methods 0.000 description 8
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 229920001223 polyethylene glycol Polymers 0.000 description 8
- 229910052710 silicon Inorganic materials 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000002202 Polyethylene glycol Substances 0.000 description 7
- 229930195733 hydrocarbon Natural products 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 6
- 102000009027 Albumins Human genes 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 6
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000006059 cover glass Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 5
- BTANRVKWQNVYAZ-UHFFFAOYSA-N Sec-butyl alcohol Natural products CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 5
- 238000005227 gel permeation chromatography Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000013076 target substance Substances 0.000 description 5
- 229910021642 ultra pure water Inorganic materials 0.000 description 5
- 239000012498 ultrapure water Substances 0.000 description 5
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 238000000572 ellipsometry Methods 0.000 description 4
- 229940052303 ethers for general anesthesia Drugs 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 125000001153 fluoro group Chemical group F* 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000012948 isocyanate Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- UCUUFSAXZMGPGH-UHFFFAOYSA-N penta-1,4-dien-3-one Chemical compound C=CC(=O)C=C UCUUFSAXZMGPGH-UHFFFAOYSA-N 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 230000008707 rearrangement Effects 0.000 description 4
- 238000001226 reprecipitation Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- WFSMVVDJSNMRAR-UHFFFAOYSA-N 2-[2-(2-ethoxyethoxy)ethoxy]ethanol Chemical compound CCOCCOCCOCCO WFSMVVDJSNMRAR-UHFFFAOYSA-N 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 3
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 3
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- 101100490446 Penicillium chrysogenum PCBAB gene Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 3
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 3
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000002073 fluorescence micrograph Methods 0.000 description 3
- 238000000799 fluorescence microscopy Methods 0.000 description 3
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 3
- FHHGCKHKTAJLOM-UHFFFAOYSA-N hexaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCO FHHGCKHKTAJLOM-UHFFFAOYSA-N 0.000 description 3
- 239000011261 inert gas Substances 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 229920001515 polyalkylene glycol Polymers 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 230000008521 reorganization Effects 0.000 description 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
- 229920001567 vinyl ester resin Polymers 0.000 description 3
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 2
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 2
- SDJHPPZKZZWAKF-UHFFFAOYSA-N 2,3-dimethylbuta-1,3-diene Chemical compound CC(=C)C(C)=C SDJHPPZKZZWAKF-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N 2-methoxyethyl acetate Chemical compound COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- BSXGCUHREZFSRY-UHFFFAOYSA-N 3-[[1-amino-2-[[1-amino-1-(2-carboxyethylimino)-2-methylpropan-2-yl]diazenyl]-2-methylpropylidene]amino]propanoic acid;tetrahydrate Chemical compound O.O.O.O.OC(=O)CCNC(=N)C(C)(C)N=NC(C)(C)C(=N)NCCC(O)=O BSXGCUHREZFSRY-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 229920002799 BoPET Polymers 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- NEAPKZHDYMQZCB-UHFFFAOYSA-N N-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]ethyl]-2-oxo-3H-1,3-benzoxazole-6-carboxamide Chemical compound C1CN(CCN1CCNC(=O)C2=CC3=C(C=C2)NC(=O)O3)C4=CN=C(N=C4)NC5CC6=CC=CC=C6C5 NEAPKZHDYMQZCB-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- 229940081735 acetylcellulose Drugs 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 238000007611 bar coating method Methods 0.000 description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- LWMFAFLIWMPZSX-UHFFFAOYSA-N bis[2-(4,5-dihydro-1h-imidazol-2-yl)propan-2-yl]diazene Chemical compound N=1CCNC=1C(C)(C)N=NC(C)(C)C1=NCCN1 LWMFAFLIWMPZSX-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- MGNZXYYWBUKAII-UHFFFAOYSA-N cyclohexa-1,3-diene Chemical compound C1CC=CC=C1 MGNZXYYWBUKAII-UHFFFAOYSA-N 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical compound C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000007607 die coating method Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000003618 dip coating Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 229920006244 ethylene-ethyl acrylate Polymers 0.000 description 2
- 229920002313 fluoropolymer Polymers 0.000 description 2
- 125000003827 glycol group Chemical group 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229920005669 high impact polystyrene Polymers 0.000 description 2
- 239000004797 high-impact polystyrene Substances 0.000 description 2
- 210000004754 hybrid cell Anatomy 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- SFLRURCEBYIKSS-UHFFFAOYSA-N n-butyl-2-[[1-(butylamino)-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound CCCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCCC SFLRURCEBYIKSS-UHFFFAOYSA-N 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 210000004623 platelet-rich plasma Anatomy 0.000 description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 229920002959 polymer blend Polymers 0.000 description 2
- 229920001955 polyphenylene ether Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920005990 polystyrene resin Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000012673 precipitation polymerization Methods 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 230000020878 pseudopodium assembly Effects 0.000 description 2
- 238000007650 screen-printing Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- JLGLQAWTXXGVEM-UHFFFAOYSA-N triethylene glycol monomethyl ether Chemical compound COCCOCCOCCO JLGLQAWTXXGVEM-UHFFFAOYSA-N 0.000 description 2
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 2
- 229960000834 vinyl ether Drugs 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- RRKODOZNUZCUBN-CCAGOZQPSA-N (1z,3z)-cycloocta-1,3-diene Chemical compound C1CC\C=C/C=C\C1 RRKODOZNUZCUBN-CCAGOZQPSA-N 0.000 description 1
- ZODNDDPVCIAZIQ-UHFFFAOYSA-N (2-hydroxy-3-prop-2-enoyloxypropyl) 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)COC(=O)C=C ZODNDDPVCIAZIQ-UHFFFAOYSA-N 0.000 description 1
- PMJHHCWVYXUKFD-SNAWJCMRSA-N (E)-1,3-pentadiene Chemical compound C\C=C\C=C PMJHHCWVYXUKFD-SNAWJCMRSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- WVAFEFUPWRPQSY-UHFFFAOYSA-N 1,2,3-tris(ethenyl)benzene Chemical compound C=CC1=CC=CC(C=C)=C1C=C WVAFEFUPWRPQSY-UHFFFAOYSA-N 0.000 description 1
- CYIGRWUIQAVBFG-UHFFFAOYSA-N 1,2-bis(2-ethenoxyethoxy)ethane Chemical compound C=COCCOCCOCCOC=C CYIGRWUIQAVBFG-UHFFFAOYSA-N 0.000 description 1
- ROLAGNYPWIVYTG-UHFFFAOYSA-N 1,2-bis(4-methoxyphenyl)ethanamine;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1CC(N)C1=CC=C(OC)C=C1 ROLAGNYPWIVYTG-UHFFFAOYSA-N 0.000 description 1
- ZJQIXGGEADDPQB-UHFFFAOYSA-N 1,2-bis(ethenyl)-3,4-dimethylbenzene Chemical group CC1=CC=C(C=C)C(C=C)=C1C ZJQIXGGEADDPQB-UHFFFAOYSA-N 0.000 description 1
- DFEVZXQWFHVLGO-UHFFFAOYSA-N 1,2-bis(ethenyl)-9h-carbazole Chemical compound C1=CC=C2NC3=C(C=C)C(C=C)=CC=C3C2=C1 DFEVZXQWFHVLGO-UHFFFAOYSA-N 0.000 description 1
- POIHBQZRXFDOPO-UHFFFAOYSA-N 1,2-bis(ethenyl)-9h-fluorene Chemical compound C1=CC=C2C3=CC=C(C=C)C(C=C)=C3CC2=C1 POIHBQZRXFDOPO-UHFFFAOYSA-N 0.000 description 1
- QLLUAUADIMPKIH-UHFFFAOYSA-N 1,2-bis(ethenyl)naphthalene Chemical compound C1=CC=CC2=C(C=C)C(C=C)=CC=C21 QLLUAUADIMPKIH-UHFFFAOYSA-N 0.000 description 1
- QTYUSOHYEPOHLV-FNORWQNLSA-N 1,3-Octadiene Chemical compound CCCC\C=C\C=C QTYUSOHYEPOHLV-FNORWQNLSA-N 0.000 description 1
- UCBVELLBUAKUNE-UHFFFAOYSA-N 1,3-bis(prop-2-enyl)-1,3,5-triazinane-2,4,6-trione Chemical compound C=CCN1C(=O)NC(=O)N(CC=C)C1=O UCBVELLBUAKUNE-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- ALVZNPYWJMLXKV-UHFFFAOYSA-N 1,9-Nonanediol Chemical compound OCCCCCCCCCO ALVZNPYWJMLXKV-UHFFFAOYSA-N 0.000 description 1
- XQUPVDVFXZDTLT-UHFFFAOYSA-N 1-[4-[[4-(2,5-dioxopyrrol-1-yl)phenyl]methyl]phenyl]pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C(C=C1)=CC=C1CC1=CC=C(N2C(C=CC2=O)=O)C=C1 XQUPVDVFXZDTLT-UHFFFAOYSA-N 0.000 description 1
- SAMJGBVVQUEMGC-UHFFFAOYSA-N 1-ethenoxy-2-(2-ethenoxyethoxy)ethane Chemical compound C=COCCOCCOC=C SAMJGBVVQUEMGC-UHFFFAOYSA-N 0.000 description 1
- IYSVFZBXZVPIFA-UHFFFAOYSA-N 1-ethenyl-4-(4-ethenylphenyl)benzene Chemical group C1=CC(C=C)=CC=C1C1=CC=C(C=C)C=C1 IYSVFZBXZVPIFA-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- XBNGYFFABRKICK-UHFFFAOYSA-N 2,3,4,5,6-pentafluorophenol Chemical compound OC1=C(F)C(F)=C(F)C(F)=C1F XBNGYFFABRKICK-UHFFFAOYSA-N 0.000 description 1
- FCMUPMSEVHVOSE-UHFFFAOYSA-N 2,3-bis(ethenyl)pyridine Chemical compound C=CC1=CC=CN=C1C=C FCMUPMSEVHVOSE-UHFFFAOYSA-N 0.000 description 1
- AVTLBBWTUPQRAY-UHFFFAOYSA-N 2-(2-cyanobutan-2-yldiazenyl)-2-methylbutanenitrile Chemical compound CCC(C)(C#N)N=NC(C)(CC)C#N AVTLBBWTUPQRAY-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- MJGLWGBXQWRFCX-UHFFFAOYSA-N 2-[(1-imino-2-methyl-1-pyrrolidin-1-ylpropan-2-yl)diazenyl]-2-methyl-1-pyrrolidin-1-ylpropan-1-imine;dihydrochloride Chemical compound Cl.Cl.C1CCCN1C(=N)C(C)(C)N=NC(C)(C)C(=N)N1CCCC1 MJGLWGBXQWRFCX-UHFFFAOYSA-N 0.000 description 1
- PFHOSZAOXCYAGJ-UHFFFAOYSA-N 2-[(2-cyano-4-methoxy-4-methylpentan-2-yl)diazenyl]-4-methoxy-2,4-dimethylpentanenitrile Chemical compound COC(C)(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)(C)OC PFHOSZAOXCYAGJ-UHFFFAOYSA-N 0.000 description 1
- WYGWHHGCAGTUCH-UHFFFAOYSA-N 2-[(2-cyano-4-methylpentan-2-yl)diazenyl]-2,4-dimethylpentanenitrile Chemical compound CC(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)C WYGWHHGCAGTUCH-UHFFFAOYSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- WAEVWDZKMBQDEJ-UHFFFAOYSA-N 2-[2-(2-methoxypropoxy)propoxy]propan-1-ol Chemical compound COC(C)COC(C)COC(C)CO WAEVWDZKMBQDEJ-UHFFFAOYSA-N 0.000 description 1
- FLKBKUFGKQPPRY-UHFFFAOYSA-N 2-[2-[2-[2-[1-(2-hydroxyethyl)-4,5-dihydroimidazol-2-yl]propan-2-yldiazenyl]propan-2-yl]-4,5-dihydroimidazol-1-yl]ethanol;dihydrochloride Chemical compound Cl.Cl.N=1CCN(CCO)C=1C(C)(C)N=NC(C)(C)C1=NCCN1CCO FLKBKUFGKQPPRY-UHFFFAOYSA-N 0.000 description 1
- XDEKOZXTBXBBAP-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-methoxypropoxy)propoxy]propoxy]propoxy]propoxy]propoxy]propan-1-ol Chemical compound COC(C)COC(C)COC(C)COC(C)COC(C)COC(C)COC(C)CO XDEKOZXTBXBBAP-UHFFFAOYSA-N 0.000 description 1
- PLQZJIIDLZRWBG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO PLQZJIIDLZRWBG-UHFFFAOYSA-N 0.000 description 1
- AKWFJQNBHYVIPY-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO AKWFJQNBHYVIPY-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- NICLKHGIKDZZGV-UHFFFAOYSA-N 2-cyanopentanoic acid Chemical compound CCCC(C#N)C(O)=O NICLKHGIKDZZGV-UHFFFAOYSA-N 0.000 description 1
- CKSAKVMRQYOFBC-UHFFFAOYSA-N 2-cyanopropan-2-yliminourea Chemical compound N#CC(C)(C)N=NC(N)=O CKSAKVMRQYOFBC-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 1
- HFCUBKYHMMPGBY-UHFFFAOYSA-N 2-methoxyethyl prop-2-enoate Chemical compound COCCOC(=O)C=C HFCUBKYHMMPGBY-UHFFFAOYSA-N 0.000 description 1
- LYPGJGCIPQYQBW-UHFFFAOYSA-N 2-methyl-2-[[2-methyl-1-oxo-1-(prop-2-enylamino)propan-2-yl]diazenyl]-n-prop-2-enylpropanamide Chemical compound C=CCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCC=C LYPGJGCIPQYQBW-UHFFFAOYSA-N 0.000 description 1
- SDQROPCSKIYYAV-UHFFFAOYSA-N 2-methyloctane-1,8-diol Chemical compound OCC(C)CCCCCCO SDQROPCSKIYYAV-UHFFFAOYSA-N 0.000 description 1
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
- VPKQPPJQTZJZDB-UHFFFAOYSA-N 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl prop-2-enoate Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CCOC(=O)C=C VPKQPPJQTZJZDB-UHFFFAOYSA-N 0.000 description 1
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 1
- BXAAQNFGSQKPDZ-UHFFFAOYSA-N 3-[1,2,2-tris(prop-2-enoxy)ethoxy]prop-1-ene Chemical compound C=CCOC(OCC=C)C(OCC=C)OCC=C BXAAQNFGSQKPDZ-UHFFFAOYSA-N 0.000 description 1
- WGKYSFRFMQHMOF-UHFFFAOYSA-N 3-bromo-5-methylpyridine-2-carbonitrile Chemical compound CC1=CN=C(C#N)C(Br)=C1 WGKYSFRFMQHMOF-UHFFFAOYSA-N 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- PAKGDPSCXSUALC-UHFFFAOYSA-N 3-methylbuta-1,2-diene Chemical compound CC(C)=C=C PAKGDPSCXSUALC-UHFFFAOYSA-N 0.000 description 1
- VSZARHUCMHICLD-UHFFFAOYSA-N 4,6-bis(prop-2-enoxy)-1h-1,3,5-triazin-2-one Chemical compound C=CCOC=1N=C(OCC=C)NC(=O)N=1 VSZARHUCMHICLD-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 208000023514 Barrett esophagus Diseases 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 239000004641 Diallyl-phthalate Substances 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- DPUYCSDGMSDKKV-MKBYFEBXSA-N N-Acetyl-L-leucyl-L-isoleucylglycyl-L-valyl-N-methyl-L-prolinamide Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC DPUYCSDGMSDKKV-MKBYFEBXSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004734 Polyphenylene sulfide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- ALBJGICXDBJZGK-UHFFFAOYSA-N [1-[(1-acetyloxy-1-phenylethyl)diazenyl]-1-phenylethyl] acetate Chemical compound C=1C=CC=CC=1C(C)(OC(=O)C)N=NC(C)(OC(C)=O)C1=CC=CC=C1 ALBJGICXDBJZGK-UHFFFAOYSA-N 0.000 description 1
- LXEKPEMOWBOYRF-UHFFFAOYSA-N [2-[(1-azaniumyl-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidoyl]azanium;dichloride Chemical compound Cl.Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N LXEKPEMOWBOYRF-UHFFFAOYSA-N 0.000 description 1
- RABVYVVNRHVXPJ-UHFFFAOYSA-N [3-(hydroxymethyl)-1-adamantyl]methanol Chemical compound C1C(C2)CC3CC1(CO)CC2(CO)C3 RABVYVVNRHVXPJ-UHFFFAOYSA-N 0.000 description 1
- KYIKRXIYLAGAKQ-UHFFFAOYSA-N abcn Chemical compound C1CCCCC1(C#N)N=NC1(C#N)CCCCC1 KYIKRXIYLAGAKQ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- IPTNXMGXEGQYSY-UHFFFAOYSA-N acetic acid;1-methoxybutan-1-ol Chemical compound CC(O)=O.CCCC(O)OC IPTNXMGXEGQYSY-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 229920001893 acrylonitrile styrene Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- MOLCWHCSXCKHAP-UHFFFAOYSA-N adamantane-1,3-diol Chemical compound C1C(C2)CC3CC1(O)CC2(O)C3 MOLCWHCSXCKHAP-UHFFFAOYSA-N 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 238000004937 angle-resolved X-ray photoelectron spectroscopy Methods 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 239000000823 artificial membrane Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000007869 azo polymerization initiator Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- WPKWPKDNOPEODE-UHFFFAOYSA-N bis(2,4,4-trimethylpentan-2-yl)diazene Chemical compound CC(C)(C)CC(C)(C)N=NC(C)(C)CC(C)(C)C WPKWPKDNOPEODE-UHFFFAOYSA-N 0.000 description 1
- MKKHTKBUMNIBLN-UHFFFAOYSA-N bis(2,4,6-trimethylphenyl)azanium;2,3,4,5,6-pentafluorobenzenesulfonate Chemical compound [O-]S(=O)(=O)C1=C(F)C(F)=C(F)C(F)=C1F.CC1=CC(C)=CC(C)=C1[NH2+]C1=C(C)C=C(C)C=C1C MKKHTKBUMNIBLN-UHFFFAOYSA-N 0.000 description 1
- ORZGJQJXBLFGRP-WAYWQWQTSA-N bis(ethenyl) (z)-but-2-enedioate Chemical compound C=COC(=O)\C=C/C(=O)OC=C ORZGJQJXBLFGRP-WAYWQWQTSA-N 0.000 description 1
- PVESJTCZIRKKLC-UHFFFAOYSA-N bis(ethenyl) 2-methylidenebutanedioate Chemical compound C=COC(=O)CC(=C)C(=O)OC=C PVESJTCZIRKKLC-UHFFFAOYSA-N 0.000 description 1
- PIPBVABVQJZSAB-UHFFFAOYSA-N bis(ethenyl) benzene-1,2-dicarboxylate Chemical compound C=COC(=O)C1=CC=CC=C1C(=O)OC=C PIPBVABVQJZSAB-UHFFFAOYSA-N 0.000 description 1
- FWICIOVOJVNAIJ-UHFFFAOYSA-N bis(ethenyl) benzene-1,3-dicarboxylate Chemical compound C=COC(=O)C1=CC=CC(C(=O)OC=C)=C1 FWICIOVOJVNAIJ-UHFFFAOYSA-N 0.000 description 1
- JZQAAQZDDMEFGZ-UHFFFAOYSA-N bis(ethenyl) hexanedioate Chemical compound C=COC(=O)CCCCC(=O)OC=C JZQAAQZDDMEFGZ-UHFFFAOYSA-N 0.000 description 1
- ZPOLOEWJWXZUSP-WAYWQWQTSA-N bis(prop-2-enyl) (z)-but-2-enedioate Chemical compound C=CCOC(=O)\C=C/C(=O)OCC=C ZPOLOEWJWXZUSP-WAYWQWQTSA-N 0.000 description 1
- QUDWYFHPNIMBFC-UHFFFAOYSA-N bis(prop-2-enyl) benzene-1,2-dicarboxylate Chemical compound C=CCOC(=O)C1=CC=CC=C1C(=O)OCC=C QUDWYFHPNIMBFC-UHFFFAOYSA-N 0.000 description 1
- FPODCVUTIPDRTE-UHFFFAOYSA-N bis(prop-2-enyl) hexanedioate Chemical compound C=CCOC(=O)CCCCC(=O)OCC=C FPODCVUTIPDRTE-UHFFFAOYSA-N 0.000 description 1
- JKRBKUNNPGKVLF-UHFFFAOYSA-N bis[2-(4,5-dihydro-1h-imidazol-2-yl)propan-2-yl]diazene;sulfo hydrogen sulfate;dihydrate Chemical compound O.O.OS(=O)(=O)OS(O)(=O)=O.N=1CCNC=1C(C)(C)N=NC(C)(C)C1=NCCN1 JKRBKUNNPGKVLF-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000012662 bulk polymerization Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- PJWNIOJGDLTZPK-UHFFFAOYSA-N cyclohexanone;methanol Chemical compound OC.O=C1CCCCC1 PJWNIOJGDLTZPK-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- FOTKYAAJKYLFFN-UHFFFAOYSA-N decane-1,10-diol Chemical compound OCCCCCCCCCCO FOTKYAAJKYLFFN-UHFFFAOYSA-N 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000012674 dispersion polymerization Methods 0.000 description 1
- WRZXKWFJEFFURH-UHFFFAOYSA-N dodecaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO WRZXKWFJEFFURH-UHFFFAOYSA-N 0.000 description 1
- TUEYHEWXYWCDHA-UHFFFAOYSA-N ethyl 5-methylthiadiazole-4-carboxylate Chemical compound CCOC(=O)C=1N=NSC=1C TUEYHEWXYWCDHA-UHFFFAOYSA-N 0.000 description 1
- OXHWMLOPJNQJJD-UHFFFAOYSA-N ethyl carbamate;3,5,5-trimethylcyclohex-2-en-1-one Chemical compound CCOC(N)=O.CC1=CC(=O)CC(C)(C)C1 OXHWMLOPJNQJJD-UHFFFAOYSA-N 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 239000005042 ethylene-ethyl acrylate Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PBZROIMXDZTJDF-UHFFFAOYSA-N hepta-1,6-dien-4-one Chemical compound C=CCC(=O)CC=C PBZROIMXDZTJDF-UHFFFAOYSA-N 0.000 description 1
- AHAREKHAZNPPMI-UHFFFAOYSA-N hexa-1,3-diene Chemical compound CCC=CC=C AHAREKHAZNPPMI-UHFFFAOYSA-N 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- GEJHIUFJTCYNSC-UHFFFAOYSA-N methyl 1-[(1-methoxycarbonylcyclohexyl)diazenyl]cyclohexane-1-carboxylate Chemical compound C1CCCCC1(C(=O)OC)N=NC1(C(=O)OC)CCCCC1 GEJHIUFJTCYNSC-UHFFFAOYSA-N 0.000 description 1
- ZQMHJBXHRFJKOT-UHFFFAOYSA-N methyl 2-[(1-methoxy-2-methyl-1-oxopropan-2-yl)diazenyl]-2-methylpropanoate Chemical compound COC(=O)C(C)(C)N=NC(C)(C)C(=O)OC ZQMHJBXHRFJKOT-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- WVFLGSMUPMVNTQ-UHFFFAOYSA-N n-(2-hydroxyethyl)-2-[[1-(2-hydroxyethylamino)-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCO WVFLGSMUPMVNTQ-UHFFFAOYSA-N 0.000 description 1
- BUGISVZCMXHOHO-UHFFFAOYSA-N n-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]-2-[[1-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCC(CO)(CO)NC(=O)C(C)(C)N=NC(C)(C)C(=O)NC(CO)(CO)CO BUGISVZCMXHOHO-UHFFFAOYSA-N 0.000 description 1
- WMRNGPYHLQSTDL-UHFFFAOYSA-N n-cyclohexyl-2-[[1-(cyclohexylamino)-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound C1CCCCC1NC(=O)C(C)(C)N=NC(C)(C)C(=O)NC1CCCCC1 WMRNGPYHLQSTDL-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- DYUWTXWIYMHBQS-UHFFFAOYSA-N n-prop-2-enylprop-2-en-1-amine Chemical compound C=CCNCC=C DYUWTXWIYMHBQS-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- VVHAVLIDQNWEKF-UHFFFAOYSA-N nonaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCO VVHAVLIDQNWEKF-UHFFFAOYSA-N 0.000 description 1
- WSGCRAOTEDLMFQ-UHFFFAOYSA-N nonan-5-one Chemical compound CCCCC(=O)CCCC WSGCRAOTEDLMFQ-UHFFFAOYSA-N 0.000 description 1
- 229920000847 nonoxynol Polymers 0.000 description 1
- SJYNFBVQFBRSIB-UHFFFAOYSA-N norbornadiene Chemical compound C1=CC2C=CC1C2 SJYNFBVQFBRSIB-UHFFFAOYSA-N 0.000 description 1
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- DBSDMAPJGHBWAL-UHFFFAOYSA-N penta-1,4-dien-3-ylbenzene Chemical compound C=CC(C=C)C1=CC=CC=C1 DBSDMAPJGHBWAL-UHFFFAOYSA-N 0.000 description 1
- IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachloro-phenol Natural products OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920003192 poly(bis maleimide) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002589 poly(vinylethylene) polymer Polymers 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 239000004631 polybutylene succinate Substances 0.000 description 1
- 229920002961 polybutylene succinate Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920005668 polycarbonate resin Polymers 0.000 description 1
- 239000004431 polycarbonate resin Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920013716 polyethylene resin Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000009719 polyimide resin Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920000069 polyphenylene sulfide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- SCUZVMOVTVSBLE-UHFFFAOYSA-N prop-2-enenitrile;styrene Chemical compound C=CC#N.C=CC1=CC=CC=C1 SCUZVMOVTVSBLE-UHFFFAOYSA-N 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 229940080818 propionamide Drugs 0.000 description 1
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 210000001243 pseudopodia Anatomy 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 239000010454 slate Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ILLKMACMBHTSHP-UHFFFAOYSA-N tetradecaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ILLKMACMBHTSHP-UHFFFAOYSA-N 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F212/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
- C08F212/34—Monomers containing two or more unsaturated aliphatic radicals
- C08F212/36—Divinylbenzene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/22—Esters containing halogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
- C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
本発明は新規な含フッ素高分岐ポリマー並びに該含フッ素高分岐ポリマーを用いて形成される生体分子吸着抑制表面(膜)に関する。 The present invention relates to a novel fluorine-containing hyperbranched polymer and a surface (membrane) for suppressing adsorption of biomolecules formed using the fluorine-containing hyperbranched polymer.
ポリマー(高分子)材料は、近年、多分野にわたってますます利用が進んでいる。それに伴い、それぞれの分野に応じて、マトリクスとしてのポリマー性状とともに、その表面や界面の特性がポリマー材料において重要となっている。特に、近年、各種の高分子材料を利用した医療材料の検討が進められており、血液フィルタ、人工腎臓用膜、血漿分離用膜、カテーテル、人工肺用膜、人工血管、癒着防止膜、人工皮膚等への利用が期待されている。この場合、生体にとって異物である合成材料を生体内組織や血液と接触させて使用することとなるため、医療材料が生体適合性を有していることが要求される。 BACKGROUND ART In recent years, polymer (polymer) materials have been increasingly used in various fields. Accordingly, the properties of the matrix as well as the properties of its surface and interface have become important in the polymer materials according to the respective fields. Particularly, in recent years, medical materials using various polymer materials have been studied, and blood filters, artificial kidney membranes, plasma separation membranes, catheters, artificial lung membranes, artificial blood vessels, adhesion prevention membranes, artificial membranes, etc. It is expected to be used for skin and the like. In this case, since the synthetic material which is a foreign substance to the living body is used in contact with the tissue or blood in the living body, the medical material is required to have biocompatibility.
一方、タンパク質や細胞をはじめとする生体成分が、使用する器具、材料等の基材表面に吸着することが問題となっている。例えば、主に医療分野において、プロテオーム解析など微量のタンパク質を測定・分析する場合に吸着成分が多いと、タンパク質の分析を正確に行うことが出来ないだけでなく、タンパク質が実質的に消失してしまう虞がある。また、人工腎臓などの体外循環の際の有用タンパク質の減少や、血小板の粘着・凝集による血栓の形成、フィブリノーゲンなどの凝固関連タンパク質の吸着による血液の凝固、といった問題が発生する。食品分野においても、製品容器への生体成分の吸着による品質低下といった問題や、生産工程中のパイプラインなどへの生体成分の吸着によるパイプラインの閉塞や劣化といった問題が発生する。 On the other hand, there is a problem that biological components such as proteins and cells are adsorbed on the surface of a base material such as instruments and materials to be used. For example, mainly in the medical field, when measuring and analyzing a small amount of protein such as proteome analysis, if there are many adsorbed components, not only can the protein analysis not be performed accurately, but also the protein is substantially lost. There is a possibility that it will end up. In addition, problems such as a decrease in useful proteins during extracorporeal circulation such as an artificial kidney, formation of a thrombus due to adhesion and aggregation of platelets, and coagulation of blood due to adsorption of a coagulation-related protein such as fibrinogen occur. In the food field as well, there are problems such as deterioration in quality due to adsorption of biological components to product containers, and problems such as blockage and deterioration of pipelines due to adsorption of biological components to pipelines during the production process.
一般的に、親水性を有する高分子は、生体分子に対する生体親和性を有し、生体分子の非特異吸着を抑制する効果があることが知られている。細胞やタンパク質成分の非特異吸着を抑制する生体親和性高分子としては、ポリエチレングリコール(PEG)又はポリエチレンオキシド(PEO)、ポリビニルピロリドン(PVP)、ポリ(2−ヒドロキシエチルメタクリレート)(PHEMA)、ポリ(2−メトキシエチルアクリレート)(PMEA)などのノニオン性高分子、及びホスホベタイン、スルホベタイン、カルボキシベタインなどの1分子中にプラス荷電とマイナス荷電の双方の官能基を有する両性高分子が挙げられる。 In general, it is known that a polymer having hydrophilicity has biocompatibility with biomolecules and has an effect of suppressing nonspecific adsorption of biomolecules. Biocompatible polymers that suppress nonspecific adsorption of cells and protein components include polyethylene glycol (PEG) or polyethylene oxide (PEO), polyvinylpyrrolidone (PVP), poly (2-hydroxyethyl methacrylate) (PHEMA), Nonionic polymers such as (2-methoxyethyl acrylate) (PMEA), and amphoteric polymers having both positively and negatively charged functional groups in one molecule such as phosphobetaine, sulfobetaine, and carboxybetaine are exemplified. .
例えば、特許文献1では、片方の末端にチオール基を有するPEOを希釈した溶液を金蒸着ガラス基材上にコーティングし、バイオチップにおけるDNAの非特異吸着をする表面の高分子材料として用いる技術が開示されている。 For example, Patent Literature 1 discloses a technique in which a solution obtained by diluting PEO having a thiol group at one end is coated on a gold-deposited glass substrate and used as a polymer material on the surface of a biochip for nonspecific adsorption of DNA. It has been disclosed.
また、非特許文献1では、PMEA及びポリメチルメタクリレート(PMMA)の高分子ブレンド溶液を基材上へスピンコーティングし、溶媒乾燥及び熱処理を施すことにより、PMEAが表面へ偏析されたPMMAブレンド膜を作製する技術が開示されている。 In Non-Patent Document 1, a polymer blend solution of PMEA and polymethyl methacrylate (PMMA) is spin-coated on a substrate, and solvent drying and heat treatment are performed to form a PMMA blend film in which PMEA is segregated on the surface. A fabrication technique is disclosed.
特許文献1に記載の片方の末端にチオール基を有するPEOは、金蒸着ガラス基材にコーティングする際、基材をその溶液に長時間浸漬する必要があり、吸着抑制表面を作製するのに非効率的な製造方法が課題であった。 The PEO having a thiol group at one end described in Patent Literature 1 needs to be immersed in the solution for a long time when coated on a gold-deposited glass substrate, and is not suitable for producing an adsorption suppression surface. An efficient manufacturing method has been a problem.
また、非特許文献1に記載の方法では、PMEA及びPMMAの高分子ブレンド溶液を基材上へスピンコーティング後、熱処理に数時間から一日を要するため、特許文献1同様に非効率的な製造方法が課題であった。 Further, in the method described in Non-Patent Document 1, heat treatment requires several hours to one day after spin-coating a polymer blend solution of PMEA and PMMA on a substrate. The method was the challenge.
本発明者らは、上記目的を達成するため鋭意検討を重ねた結果、フルオロアルキル基及び分子末端にオキシアルキレン部位を有する含フッ素高分岐ポリマー、並びに熱可塑性樹脂を含む樹脂ブレンドが、スピンコーティングなどの短時間で薄膜を作製可能な塗布方法により、プラスチックをはじめとする各種基材上に、簡便にタンパク質などの生体分子の吸着を抑制可能な表面を形成可能となることを見出し、本発明を完成させた。 The present inventors have conducted intensive studies to achieve the above object, and as a result, a resin blend containing a fluoroalkyl group and a fluorinated hyperbranched polymer having an oxyalkylene moiety at a molecular terminal, and a resin blend containing a thermoplastic resin have been spin-coated and the like It has been found that a coating method that can produce a thin film in a short time can easily form a surface capable of suppressing the adsorption of biomolecules such as proteins on various substrates such as plastics. Completed.
すなわち本発明は、第1観点として、分子内に2個以上のラジカル重合性二重結合を有するモノマーAと、分子内にフルオロアルキル基及び少なくとも1個のラジカル重合性二重結合を有するモノマーBとを少なくとも含む重合性化合物を、該モノマーAのモル数に対して5〜200モル%の重合開始剤Cの存在下で重合させることにより得られる含フッ素高分岐ポリマーであって、その分子末端に式[1]で表されるオキシアルキレン部位を有する、含フッ素高分岐ポリマーに関する。
第2観点として、前記nが1乃至30の整数である、第1観点に記載の含フッ素高分岐ポリマーに関する。
第3観点として、前記オキシアルキレン部位が、重合開始剤Cの断片を介してその分子末端に結合している、第1観点又は第2観点に記載の含フッ素高分岐ポリマーに関する。
第4観点として、前記モノマーAが、ビニル基又は(メタ)アクリル基の何れか一方又は双方を有する化合物である、第1観点乃至第3観点のうち何れか一項に記載の含フッ素高分岐ポリマーに関する。
第5観点として、前記モノマーAが、ジビニル化合物又はジ(メタ)アクリレート化合物である、第4観点に記載の含フッ素高分岐ポリマーに関する。
第6観点として、前記モノマーAがジビニルベンゼンである、第5観点に記載の含フッ素高分岐ポリマーに関する。
第7観点として、前記モノマーBが、ビニル基又は(メタ)アクリル基の何れか一方を少なくとも1つ有する化合物である、第1観点乃至第6観点のうち何れか一項に記載の含フッ素高分岐ポリマーに関する。
第8観点として、前記モノマーBが式[2]で表される化合物である、第7観点に記載の含フッ素高分岐ポリマーに関する。
第9観点として、前記重合開始剤Cがアゾ系重合開始剤である、第1観点乃至第8観点のうち何れか一項に記載の含フッ素高分岐ポリマーに関する。
第10観点として、第1観点乃至第9観点のうち何れか一項に記載の含フッ素高分岐ポリマーを含有するワニスに関する。
第11観点として、第1観点乃至第9観点のうち何れか一項に記載の含フッ素高分岐ポリマーより作製される生体分子吸着抑制能を有する薄膜に関する。
第12観点として、(a)第1観点乃至第9観点のうち何れか一項に記載の含フッ素高分岐ポリマー、及び(b)熱可塑性樹脂を含む樹脂ブレンドに関する。
第13観点として、第12観点に記載の樹脂ブレンドより作製される生体分子吸着抑制膜に関する。
第14観点として、分子内に2個以上のラジカル重合性二重結合を有するモノマーAと、分子内にフルオロアルキル基及び少なくとも1個のラジカル重合性二重結合を有するモノマーBとを少なくとも含む重合性化合物を、該モノマーAのモル数に対して5〜200モル%の分子内にカルボキシ基を有する重合開始剤の存在下で重合させることにより得られるカルボキシ基含有含フッ素高分岐ポリマー、又はそのカルボキシ基活性化体と、式[3]で表される化合物とを反応させることを特徴とする、第1観点乃至第9観点のうち何れか一項に記載の含フッ素高分岐ポリマーの製造方法に関する。
第15観点として、前記nが1乃至30の整数である、第14観点に記載の製造方法に関する。
第16観点として、第1観点乃至第9観点のうち何れか一項に記載の含フッ素高分岐ポリマーより作製される生体分子吸着抑制能を有する薄膜の製造方法であって、
該含フッ素高分岐ポリマーを溶媒中に含む液をスピンコート法により基材上に塗布し、塗膜を形成する工程、及び
該塗膜を乾燥し溶媒を除去する工程
を含む、生体分子吸着抑制能を有する薄膜の製造方法に関する。
第17観点として、第12観点に記載の樹脂ブレンドより作製される生体分子吸着抑制膜の製造方法であって、
該樹脂ブレンドを溶媒中に含む液をスピンコート法により基材上に塗布し、塗膜を形成する工程、及び
該塗膜を乾燥し溶媒を除去する工程
を含む、生体分子吸着抑制膜の製造方法に関する。That is, the present invention provides, as a first aspect, a monomer A having two or more radically polymerizable double bonds in a molecule and a monomer B having a fluoroalkyl group and at least one radically polymerizable double bond in a molecule. And a polymerizable compound containing at least 5 to 200 mol% of a polymerization initiator C with respect to the number of moles of the monomer A, and a fluorine-containing hyperbranched polymer obtained by polymerizing the polymerizable compound. And a fluorinated hyperbranched polymer having an oxyalkylene moiety represented by Formula [1].
As a second aspect, the present invention relates to the fluorine-containing hyperbranched polymer according to the first aspect, wherein n is an integer of 1 to 30.
As a third aspect, the present invention relates to the fluorine-containing hyperbranched polymer according to the first aspect or the second aspect, wherein the oxyalkylene moiety is bonded to a molecular terminal of the polymerization initiator C via a fragment thereof.
As a fourth aspect, the fluorinated hyperbranch according to any one of the first to third aspects, wherein the monomer A is a compound having one or both of a vinyl group and a (meth) acryl group. For polymers.
As a fifth aspect, the present invention relates to the fluorine-containing hyperbranched polymer according to the fourth aspect, wherein the monomer A is a divinyl compound or a di (meth) acrylate compound.
As a sixth aspect, the present invention relates to the fluorinated hyperbranched polymer according to the fifth aspect, wherein the monomer A is divinylbenzene.
As a seventh aspect, the monomer B is a compound having at least one of a vinyl group and a (meth) acryl group, and the fluorine-containing high content according to any one of the first to sixth aspects. Related to branched polymers.
As an eighth aspect, the present invention relates to the fluorine-containing hyperbranched polymer according to the seventh aspect, wherein the monomer B is a compound represented by the formula [2].
As a ninth aspect, the present invention relates to the fluorinated hyperbranched polymer according to any one of the first to eighth aspects, wherein the polymerization initiator C is an azo-based polymerization initiator.
As a tenth aspect, the present invention relates to a varnish containing the fluorinated hyperbranched polymer according to any one of the first to ninth aspects.
As an eleventh aspect, the present invention relates to a thin film having a biomolecule adsorption suppressing ability, which is produced from the fluorinated hyperbranched polymer according to any one of the first to ninth aspects.
As a twelfth aspect, the present invention relates to a resin blend containing (a) the fluorinated hyperbranched polymer according to any one of the first to ninth aspects, and (b) a thermoplastic resin.
As a thirteenth aspect, the present invention relates to a biomolecule adsorption suppressing film produced from the resin blend according to the twelfth aspect.
As a fourteenth aspect, a polymerization including at least a monomer A having two or more radically polymerizable double bonds in a molecule and a monomer B having a fluoroalkyl group and at least one radically polymerizable double bond in a molecule Group-containing fluorinated hyperbranched polymer obtained by polymerizing an acidic compound in the presence of a polymerization initiator having a carboxy group in the molecule of 5 to 200 mol% based on the number of moles of the monomer A, or The method for producing a fluorine-containing hyperbranched polymer according to any one of the first to ninth aspects, wherein the activated carboxy group is reacted with a compound represented by the formula [3]. About.
As a fifteenth aspect, the present invention relates to the manufacturing method according to the fourteenth aspect, wherein n is an integer of 1 to 30.
As a sixteenth aspect, a method for producing a thin film having a biomolecule adsorption-suppressing ability, which is produced from the fluorine-containing hyperbranched polymer according to any one of the first to ninth aspects,
A step of applying a liquid containing the fluorinated hyperbranched polymer in a solvent onto a substrate by a spin coating method to form a coating film, and a step of drying the coating film and removing the solvent to suppress biomolecule adsorption. The present invention relates to a method for producing a thin film having a function.
As a seventeenth aspect, there is provided a method for producing a biomolecule adsorption suppression membrane produced from the resin blend according to the twelfth aspect,
Production of a biomolecule adsorption suppressing film, comprising a step of applying a liquid containing the resin blend in a solvent to a substrate by a spin coating method to form a coating film, and a step of drying the coating film and removing the solvent. About the method.
本発明の、分子末端に、生体分子の吸着を抑制する効果を有するオキシアルキレン部位を有する含フッ素高分岐ポリマーは、該ポリマーを含有するワニスや該ポリマーを含有する樹脂ブレンド等を用いて、スピンコーティングにより容易に膜を形成でき、短時間で基材上にタンパク質などの生体分子の吸着を抑制可能な表面を作製することが可能となる。
また本発明の分子末端にオキシアルキレン部位を有する含フッ素高分岐ポリマーは、積極的に枝分かれ構造を導入しているため、線状高分子と比較して分子間の絡み合いが少なく微粒子的挙動を示す。さらにフルオロアルキル基により低表面エネルギー化された含フッ素高分岐ポリマーは、マトリクスとなる熱可塑性樹脂中においては、空気などの自由界面である表面側への移動が容易となり、樹脂表面に活性を付与しやすい。従って、本発明の分子末端にオキシアルキレン部位を有する含フッ素高分岐ポリマーと上記熱可塑性樹脂等を含む樹脂ブレンドから膜などの成形体を作製する際、微粒子状の該含フッ素高分岐ポリマーは界面(膜表面)に容易に移動することができ、その表面において該含フッ素高分岐ポリマーの存在量が高められた成形体(膜)を形成可能である。すなわち、本発明の分子末端にオキシアルキレン部位を有する含フッ素高分岐ポリマーに熱可塑性樹脂等を配合した樹脂ブレンドから、その表面がタンパク質などの生体分子の吸着を抑制可能な表面である成形体(膜)等を形成できる。According to the present invention, a fluorine-containing hyperbranched polymer having an oxyalkylene moiety having an effect of suppressing the adsorption of a biomolecule at a molecular terminal is spin-coated using a varnish containing the polymer or a resin blend containing the polymer. A film can be easily formed by coating, and a surface capable of suppressing adsorption of biomolecules such as proteins on a substrate in a short time can be produced.
In addition, since the fluorine-containing hyperbranched polymer having an oxyalkylene moiety at the molecular terminal of the present invention has a positively introduced branched structure, it has less entanglement between molecules than linear polymers and exhibits a fine particle behavior. . Furthermore, the fluorine-containing hyperbranched polymer whose surface energy is reduced by the fluoroalkyl group makes it easy for air and other substances to move to the surface side, which is a free interface, in the thermoplastic resin used as the matrix, and imparts activity to the resin surface It's easy to do. Therefore, when producing a molded article such as a film from a resin blend containing the above-mentioned thermoplastic resin and a fluorine-containing hyperbranched polymer having an oxyalkylene site at the molecular terminal of the present invention, the finely divided fluorine-containing hyperbranched polymer in the form of an interface (A membrane surface), and a molded article (membrane) in which the amount of the fluorine-containing hyperbranched polymer is increased on the surface can be formed. That is, from a resin blend of the present invention in which a thermoplastic resin or the like is blended with a fluorine-containing hyperbranched polymer having an oxyalkylene site at a molecular terminal, a molded body whose surface is a surface capable of suppressing adsorption of biomolecules such as proteins ( Film) can be formed.
<含フッ素高分岐ポリマー>
本発明の含フッ素高分岐ポリマーは、分子内に2個以上のラジカル重合性二重結合を有するモノマーAと、分子内にフルオロアルキル基及び少なくとも1個のラジカル重合性二重結合を有するモノマーBとを少なくとも含む重合性化合物を、該モノマーAのモル数に対して5〜200モル%の重合開始剤Cの存在下で重合させることにより得られる含フッ素高分岐ポリマーであって、その分子末端に前記式[1]で表されるオキシアルキレン部位を有するポリマーである。
なお、前記含フッ素高分岐ポリマーは、いわゆる開始剤断片組込み(IFIRP)型高分岐ポリマーであり、その末端に重合に使用した重合開始剤Cの断片を有している。そして好ましくは、前記式[1]で表されるオキシアルキレン部位は、前記重合開始剤Cの断片を介してその分子末端に結合している。
さらに、上記含フッ素高分岐ポリマーは、本発明の効果を損なわない限り、後述のモノマーA及びモノマーBに属さない多官能モノマー及び/又は単官能モノマーを、必要に応じて共重合させてもよい。<Fluorine-containing hyperbranched polymer>
The fluorinated hyperbranched polymer of the present invention comprises a monomer A having two or more radically polymerizable double bonds in a molecule and a monomer B having a fluoroalkyl group and at least one radically polymerizable double bond in a molecule. And a polymerizable compound containing at least 5 to 200 mol% of a polymerization initiator C with respect to the number of moles of the monomer A, and a fluorine-containing hyperbranched polymer obtained by polymerizing the polymerizable compound. And a polymer having an oxyalkylene moiety represented by the formula [1].
The fluorinated hyperbranched polymer is a so-called initiator fragment incorporation (IFIRP) type hyperbranched polymer, and has a fragment of the polymerization initiator C used for polymerization at its terminal. Preferably, the oxyalkylene moiety represented by the formula [1] is bonded to a molecular terminal of the polymerization initiator C via a fragment of the polymerization initiator C.
Furthermore, as long as the effect of the present invention is not impaired, the fluorine-containing hyperbranched polymer may be copolymerized with a polyfunctional monomer and / or a monofunctional monomer that does not belong to the monomers A and B described below. .
[モノマーA]
本発明において、分子内に2個以上のラジカル重合性二重結合を有するモノマーAは、ビニル基又は(メタ)アクリル基の何れか一方を少なくとも1つ有することが好ましく、特にジビニル化合物又はジ(メタ)アクリレート化合物であることが好ましい。
なお、本発明では(メタ)アクリレート化合物とは、アクリレート化合物とメタクリレート化合物の両方をいう。例えば(メタ)アクリル酸は、アクリル酸とメタクリル酸をいう。[Monomer A]
In the present invention, the monomer A having two or more radically polymerizable double bonds in the molecule preferably has at least one of a vinyl group and a (meth) acryl group, and particularly a divinyl compound or a di ( It is preferably a meth) acrylate compound.
In the present invention, the (meth) acrylate compound refers to both an acrylate compound and a methacrylate compound. For example, (meth) acrylic acid refers to acrylic acid and methacrylic acid.
前記分子内に2個以上のラジカル重合性二重結合を有するモノマーAとしては、例えば、以下の(A1)乃至(A5)に示した化合物が挙げられる。 Examples of the monomer A having two or more radically polymerizable double bonds in the molecule include the following compounds (A1) to (A5).
(A1)ビニル系炭化水素類:
(A1−1)脂肪族ビニル系炭化水素類;イソプレン、ブタジエン、3−メチル−1,2−ブタジエン、2,3−ジメチル−1,3−ブタジエン、1,2−ポリブタジエン、ペンタジエン、ヘキサジエン、オクタジエン等。
(A1−2)脂環式ビニル系炭化水素類;シクロペンタジエン、シクロヘキサジエン、シクロオクタジエン、ノルボルナジエン等。
(A1−3)芳香族ビニル系炭化水素類;ジビニルベンゼン、ジビニルトルエン、ジビニルキシレン、トリビニルベンゼン、ジビニルビフェニル、ジビニルナフタレン、ジビニルフルオレン、ジビニルカルバゾール、ジビニルピリジン等。(A1) Vinyl hydrocarbons:
(A1-1) Aliphatic vinyl hydrocarbons; isoprene, butadiene, 3-methyl-1,2-butadiene, 2,3-dimethyl-1,3-butadiene, 1,2-polybutadiene, pentadiene, hexadiene, octadiene etc.
(A1-2) Alicyclic vinyl hydrocarbons; cyclopentadiene, cyclohexadiene, cyclooctadiene, norbornadiene and the like.
(A1-3) Aromatic vinyl hydrocarbons; divinylbenzene, divinyltoluene, divinylxylene, trivinylbenzene, divinylbiphenyl, divinylnaphthalene, divinylfluorene, divinylcarbazole, divinylpyridine and the like.
(A2)ビニルエステル、アリルエステル、ビニルエーテル、アリルエーテル及びビニルケトン:
(A2−1)ビニルエステル;アジピン酸ジビニル、マレイン酸ジビニル、フタル酸ジビニル、イソフタル酸ジビニル、イタコン酸ジビニル、ビニル(メタ)アクリレート等。
(A2−2)アリルエステル;マレイン酸ジアリル、フタル酸ジアリル、イソフタル酸ジアリル、アジピン酸ジアリル、アリル(メタ)アクリレート等。
(A2−3)ビニルエーテル;ジビニルエーテル、ジエチレングリコールジビニルエーテル、トリエチレングリコールジビニルエーテル等。
(A2−4)アリルエーテル;ジアリルエーテル、ジアリルオキシエタン、トリアリルオキシエタン、テトラアリルオキシエタン、テトラアリルオキシプロパン、テトラアリルオキシブタン、テトラメタリルオキシエタン等。
(A2−5)ビニルケトン;ジビニルケトン、ジアリルケトン等。(A2) Vinyl ester, allyl ester, vinyl ether, allyl ether and vinyl ketone:
(A2-1) Vinyl esters; divinyl adipate, divinyl maleate, divinyl phthalate, divinyl isophthalate, divinyl itaconate, vinyl (meth) acrylate and the like.
(A2-2) Allyl esters: diallyl maleate, diallyl phthalate, diallyl isophthalate, diallyl adipate, allyl (meth) acrylate and the like.
(A2-3) Vinyl ethers: divinyl ether, diethylene glycol divinyl ether, triethylene glycol divinyl ether and the like.
(A2-4) Allyl ether; diallyl ether, diallyloxyethane, triallyloxyethane, tetraallyloxyethane, tetraallyloxypropane, tetraallyloxybutane, tetramethallyloxyethane and the like.
(A2-5) Vinyl ketone; divinyl ketone, diallyl ketone and the like.
(A3)(メタ)アクリル酸エステル:
エチレングリコールジ(メタ)アクリレート、ジエチレングリコールジ(メタ)アクリレート、トリエチレングリコールジ(メタ)アクリレート、テトラエチレングリコールジ(メタ)アクリレート、ノナエチレングリコールジ(メタ)アクリレート、トリメチレングリコールジ(メタ)アクリレート、プロピレングリコールジ(メタ)アクリレート、ジプロピレングリコールジ(メタ)アクリレート、トリプロピレングリコールジ(メタ)アクリレート、テトラメチレングリコールジ(メタ)アクリレート、ネオペンチルグリコールジ(メタ)アクリレート、1,6−ヘキサンジオールジ(メタ)アクリレート、2−メチル−1,8−オクタンジオールジ(メタ)アクリレート、1,9−ノナンジオールジ(メタ)アクリレート、1,10−デカンジオールジ(メタ)アクリレート、トリメチロールプロパントリ(メタ)アクリレート、ジトリメチロールプロパンテトラ(メタ)アクリレート、2−ヒドロキシ−1−アクリロイルオキシ−3−メタクリロイルオキシプロパン、2−ヒドロキシ−1,3−ジ(メタ)アクリロイルオキシプロパン、グリセリン=トリ(メタ)アクリレート、ペンタエリスリトールテトラ(メタ)アクリレート、ジオキサングリコールジ(メタ)アクリレート、トリシクロ[5.2.1.02,6]デカンジメタノールジ(メタ)アクリレート、1,3−アダマンタンジオールジ(メタ)アクリレート、1,3−アダマンタンジメタノールジ(メタ)アクリレート、9,9−ビス[4−(2−(メタ)アクリロイルオキシエトキシ)フェニル]フルオレン、ビス[2−(メタ)アクリロイルチオエチル]スルフィド、ビス[4−(メタ)アクリロイルチオフェニル]スルフィド、アルコキシチタントリ(メタ)アクリレート、イソホロンウレタンジ(メタ)アクリレート、脂肪族ウレタンジ(メタ)アクリレート、芳香族ウレタンジ(メタ)アクリレート等。(A3) (meth) acrylic acid ester:
Ethylene glycol di (meth) acrylate, diethylene glycol di (meth) acrylate, triethylene glycol di (meth) acrylate, tetraethylene glycol di (meth) acrylate, nonaethylene glycol di (meth) acrylate, trimethylene glycol di (meth) acrylate , Propylene glycol di (meth) acrylate, dipropylene glycol di (meth) acrylate, tripropylene glycol di (meth) acrylate, tetramethylene glycol di (meth) acrylate, neopentyl glycol di (meth) acrylate, 1,6-hexane Diol di (meth) acrylate, 2-methyl-1,8-octanediol di (meth) acrylate, 1,9-nonanediol di (meth) acrylate, 1,10 Decanediol di (meth) acrylate, trimethylolpropane tri (meth) acrylate, ditrimethylolpropanetetra (meth) acrylate, 2-hydroxy-1-acryloyloxy-3-methacryloyloxypropane, 2-hydroxy-1,3-di (Meth) acryloyloxypropane, glycerin tri (meth) acrylate, pentaerythritol tetra (meth) acrylate, dioxane glycol di (meth) acrylate, tricyclo [5.2.1.0 2,6 ] decanedimethanol di (meth) ) Acrylate, 1,3-adamantanediol di (meth) acrylate, 1,3-adamantane dimethanol di (meth) acrylate, 9,9-bis [4- (2- (meth) acryloyloxyethoxy) phenyl] fluoro Len, bis [2- (meth) acryloylthioethyl] sulfide, bis [4- (meth) acryloylthiophenyl] sulfide, alkoxytitanium tri (meth) acrylate, isophorone urethane di (meth) acrylate, aliphatic urethane di (meth) Acrylate, aromatic urethane di (meth) acrylate and the like.
(A4)ポリアルキレングリコール鎖を有するビニル系化合物:
ポリエチレングリコール(分子量:200,300,400,600,1000など)ジ(メタ)アクリレート、ポリプロピレングリコール(分子量:400,500,700など)ジ(メタ)アクリレート、ポリテトラメチレングリコール(分子量:650など)ジ(メタ)アクリレート、エチレンオキシド付加ポリプロピレングリコール(分子量:700など)ジ(メタ)アクリレート等。(A4) Vinyl compound having a polyalkylene glycol chain:
Polyethylene glycol (molecular weight: 200, 300, 400, 600, 1000, etc.) di (meth) acrylate, polypropylene glycol (molecular weight: 400, 500, 700, etc.) di (meth) acrylate, polytetramethylene glycol (molecular weight: 650, etc.) Di (meth) acrylate, ethylene oxide-added polypropylene glycol (molecular weight: 700, etc.) di (meth) acrylate and the like.
(A5)含窒素ビニル系化合物:
ジアリルアミン、ジアリルイソシアヌレート、ジアリルシアヌレート、メチレンビス(メタ)アクリルアミド、ビスマレイミド等。(A5) Nitrogen-containing vinyl compound:
Diallylamine, diallyl isocyanurate, diallyl cyanurate, methylene bis (meth) acrylamide, bismaleimide and the like.
これらモノマーAは単独で使用してもよいし、2種類以上を併用しても構わない。 These monomers A may be used alone or in combination of two or more.
これらのうち好ましいものは、上記(A1−3)群の芳香族ビニル系炭化水素類、(A2)群のビニルエステル、アリルエステル、ビニルエーテル、アリルエーテル及びビニルケトン、(A3)群の(メタ)アクリル酸エステル、(A4)群のポリアルキレングリコール鎖を有するビニル系化合物、並びに(A5)群の含窒素ビニル系化合物であり、より好ましくは上記(A1−3)群の芳香族ビニル系炭化水素類、(A3)群の(メタ)アクリル酸エステルである。これらの中でも後述する熱可塑性樹脂への分散性の観点から、特にジビニルベンゼン、エチレングリコールジ(メタ)アクリレートが好ましい。 Among these, preferred are the above-mentioned aromatic vinyl hydrocarbons of the group (A1-3), vinyl esters, allyl esters, vinyl ethers, allyl ethers and vinyl ketones of the group (A2), and (meth) acrylic groups of the group (A3). Acid esters, vinyl compounds having a polyalkylene glycol chain of the group (A4), and nitrogen-containing vinyl compounds of the group (A5), more preferably the aromatic vinyl hydrocarbons of the above group (A1-3) , (A3) group (meth) acrylates. Among these, divinylbenzene and ethylene glycol di (meth) acrylate are particularly preferable from the viewpoint of dispersibility in a thermoplastic resin described later.
[モノマーB]
本発明において、分子内にフルオロアルキル基及び少なくとも1個のラジカル重合性二重結合を有するモノマーBは、好ましくはビニル基又は(メタ)アクリル基の何れか一方を少なくとも1つ有することが望ましい。
例えばモノマーBとしては、上記式[2]で表される化合物が挙げられ、より好ましい具体例として下記式[4]で表される化合物を挙げることができる。
In the present invention, the monomer B having a fluoroalkyl group and at least one radical polymerizable double bond in the molecule preferably has at least one of a vinyl group and a (meth) acryl group.
For example, as the monomer B, a compound represented by the above formula [2] can be mentioned, and as a more preferable specific example, a compound represented by the following formula [4] can be mentioned.
このようなモノマーBとしては、例えば、2,2,2−トリフルオロエチル(メタ)アクリレート、2,2,3,3,3−ペンタフルオロプロピル(メタ)アクリレート、2−(パーフルオロブチル)エチル(メタ)アクリレート、2−(パーフルオロヘキシル)エチル(メタ)アクリレート、2−(パーフルオロオクチル)エチル(メタ)アクリレート、2−(パーフルオロデシル)エチル(メタ)アクリレート、2−(パーフルオロ−3−メチルブチル)エチル(メタ)アクリレート、2−(パーフルオロ−5−メチルヘキシル)エチル(メタ)アクリレート、2−(パーフルオロ−7−メチルオクチル)エチル(メタ)アクリレート、1H,1H,3H−テトラフルオロプロピル(メタ)アクリレート、1H,1H,5H−オクタフルオロペンチル(メタ)アクリレート、1H,1H,7H−ドデカフルオロヘプチル(メタ)アクリレート、1H,1H,9H−ヘキサデカフルオロノニル(メタ)アクリレート、1H−1−(トリフルオロメチル)トリフルオロエチル(メタ)アクリレート、1H,1H,3H−ヘキサフルオロブチル(メタ)アクリレート、3−パーフルオロブチル−2−ヒドロキシプロピル(メタ)アクリレート、3−パーフルオロヘキシル−2−ヒドロキシプロピル(メタ)アクリレート、3−パーフルオロオクチル−2−ヒドロキシプロピル(メタ)アクリレート、3−(パーフルオロ−3−メチルブチル)−2−ヒドロキシプロピル(メタ)アクリレート、3−(パーフルオロ−5−メチルヘキシル)−2−ヒドロキシプロピル(メタ)アクリレート、3−(パーフルオロ−7−メチルオクチル)−2−ヒドロキシプロピル(メタ)アクリレート等が挙げられる。 Examples of such a monomer B include 2,2,2-trifluoroethyl (meth) acrylate, 2,2,3,3,3-pentafluoropropyl (meth) acrylate, and 2- (perfluorobutyl) ethyl (Meth) acrylate, 2- (perfluorohexyl) ethyl (meth) acrylate, 2- (perfluorooctyl) ethyl (meth) acrylate, 2- (perfluorodecyl) ethyl (meth) acrylate, 2- (perfluoro- 3-methylbutyl) ethyl (meth) acrylate, 2- (perfluoro-5-methylhexyl) ethyl (meth) acrylate, 2- (perfluoro-7-methyloctyl) ethyl (meth) acrylate, 1H, 1H, 3H- Tetrafluoropropyl (meth) acrylate, 1H, 1H, 5H-octaflu Lopentyl (meth) acrylate, 1H, 1H, 7H-dodecafluoroheptyl (meth) acrylate, 1H, 1H, 9H-hexadecafluorononyl (meth) acrylate, 1H-1- (trifluoromethyl) trifluoroethyl (meth) Acrylate, 1H, 1H, 3H-hexafluorobutyl (meth) acrylate, 3-perfluorobutyl-2-hydroxypropyl (meth) acrylate, 3-perfluorohexyl-2-hydroxypropyl (meth) acrylate, 3-perfluoro Octyl-2-hydroxypropyl (meth) acrylate, 3- (perfluoro-3-methylbutyl) -2-hydroxypropyl (meth) acrylate, 3- (perfluoro-5-methylhexyl) -2-hydroxypropyl (meth) Ace relay 3- (perfluoro-7-methyl-octyl) -2-hydroxypropyl (meth) acrylate.
本発明において、モノマーBの使用量は、反応性や表面改質効果の観点から、前記モノマーAの使用モル数に対して5〜300モル%、特に10〜150モル%の量で、より好ましくは20〜100モル%の量で使用することが好ましい。 In the present invention, the amount of the monomer B is more preferably 5 to 300 mol%, particularly preferably 10 to 150 mol%, based on the number of moles of the monomer A, from the viewpoint of reactivity and surface modification effect. Is preferably used in an amount of 20 to 100 mol%.
[重合開始剤C]
上記重合開始剤Cとしては、好ましくはアゾ系重合開始剤が用いられる。アゾ系重合開始剤としては、例えば以下の(1)〜(5)に示す化合物を挙げることができる。
(1)アゾニトリル化合物:
2,2’−アゾビスイソブチロニトリル、2,2’−アゾビス(2−メチルブチロニトリル)、2,2’−アゾビス(2,4−ジメチルバレロニトリル)、1,1’−アゾビス(1−シクロヘキサンカルボニトリル)、2,2’−アゾビス(4−メトキシ−2,4−ジメチルバレロニトリル)、2−(カルバモイルアゾ)イソブチロニトリル等;
(2)アゾアミド化合物:
2,2’−アゾビス{2−メチル−N−[1,1−ビス(ヒドロキシメチル)−2−ヒドロキシエチル]プロピオンアミド}、2,2’−アゾビス{2−メチル−N−[2−(1−ヒドロキシブチル)]プロピオンアミド}、2,2’−アゾビス[2−メチル−N−(2−ヒドロキシエチル)プロピオンアミド]、2,2’−アゾビス[N−(2−プロペニル)−2−メチルプロピオンアミド]、2,2’−アゾビス(N−ブチル−2−メチルプロピオンアミド)、2,2’−アゾビス(N−シクロヘキシル−2−メチルプロピオンアミド)等;
(3)環状アゾアミジン化合物:
2,2’−アゾビス[2−(2−イミダゾリン−2−イル)プロパン]ジヒドロクロリド、2,2’−アゾビス[2−(2−イミダゾリン−2−イル)プロパン]ジスルフェートジヒドレート、2,2’−アゾビス[2−[1−(2−ヒドロキシエチル)−2−イミダゾリン−2−イル]プロパン]ジヒドロクロリド、2,2’−アゾビス[2−(2−イミダゾリン−2−イル)プロパン]、2,2’−アゾビス(1−イミノ−1−ピロリジノ−2−メチルプロパン)ジヒドロクロリド等;
(4)アゾアミジン化合物:
2,2’−アゾビス(2−メチルプロピオンアミジン)ジヒドロクロリド、2,2’−アゾビス[N−(2−カルボキシエチル)−2−メチルプロピオンアミジン]テトラヒドレート等;
(5)その他:
2,2’−アゾビスイソ酪酸ジメチル、4,4’−アゾビス(4−シアノバレリン酸)、2,2’−アゾビス(2,4,4−トリメチルペンタン)、1,1’−アゾビス(1−アセトキシ−1−フェニルエタン)、ジメチル1,1’−アゾビス(1−シクロヘキサンカルボキシレート)等。[Polymerization initiator C]
As the polymerization initiator C, preferably, an azo-based polymerization initiator is used. Examples of the azo polymerization initiator include the following compounds (1) to (5).
(1) Azonitrile compound:
2,2′-azobisisobutyronitrile, 2,2′-azobis (2-methylbutyronitrile), 2,2′-azobis (2,4-dimethylvaleronitrile), 1,1′-azobis ( 1-cyclohexanecarbonitrile), 2,2′-azobis (4-methoxy-2,4-dimethylvaleronitrile), 2- (carbamoylazo) isobutyronitrile, and the like;
(2) Azoamide compound:
2,2′-azobis {2-methyl-N- [1,1-bis (hydroxymethyl) -2-hydroxyethyl] propionamide}, 2,2′-azobis {2-methyl-N- [2- ( 1-hydroxybutyl)] propionamide}, 2,2′-azobis [2-methyl-N- (2-hydroxyethyl) propionamide], 2,2′-azobis [N- (2-propenyl) -2- Methylpropionamide], 2,2′-azobis (N-butyl-2-methylpropionamide), 2,2′-azobis (N-cyclohexyl-2-methylpropionamide) and the like;
(3) Cyclic azoamidine compound:
2,2′-azobis [2- (2-imidazolin-2-yl) propane] dihydrochloride, 2,2′-azobis [2- (2-imidazolin-2-yl) propane] disulfate dihydrate, 2,2′-azobis [2- [1- (2-hydroxyethyl) -2-imidazolin-2-yl] propane] dihydrochloride, 2,2′-azobis [2- (2-imidazolin-2-yl) Propane], 2,2′-azobis (1-imino-1-pyrrolidino-2-methylpropane) dihydrochloride and the like;
(4) Azoamidine compound:
2,2′-azobis (2-methylpropionamidine) dihydrochloride, 2,2′-azobis [N- (2-carboxyethyl) -2-methylpropionamidine] tetrahydrate, and the like;
(5) Others:
Dimethyl 2,2'-azobisisobutyrate, 4,4'-azobis (4-cyanovaleric acid), 2,2'-azobis (2,4,4-trimethylpentane), 1,1'-azobis (1-acetoxy- 1-phenylethane), dimethyl 1,1′-azobis (1-cyclohexanecarboxylate) and the like.
上記アゾ系重合開始剤は一種を単独で、或いは二種以上を組み合わせて使用してもよい。
これらアゾ系重合開始剤の中でも、後述する本発明の含フッ素高分岐ポリマーにおける前記式[1]で表されるオキシアルキレン部位の導入のしやすさの観点から4,4’−アゾビス(4−シアノバレリン酸)、2,2’−アゾビス[N−(2−カルボキシエチル)−2−メチルプロピオンアミジン]テトラヒドレート等が好ましい。The azo-based polymerization initiators may be used alone or in combination of two or more.
Among these azo-based polymerization initiators, 4,4′-azobis (4- (4,4 ′)-azobis (4-) is preferable from the viewpoint of easy introduction of the oxyalkylene moiety represented by the formula [1] in the fluorine-containing highly branched polymer of the present invention described below. Preferred are cyanovaleric acid) and 2,2′-azobis [N- (2-carboxyethyl) -2-methylpropionamidine] tetrahydrate.
前記重合開始剤Cは、前記モノマーAのモル数に対して、5〜200モル%の量で使用され、好ましくは20〜200モル%の量で、より好ましくは20〜100モル%の量で使用される。 The polymerization initiator C is used in an amount of 5 to 200 mol%, preferably 20 to 200 mol%, more preferably 20 to 100 mol%, based on the number of moles of the monomer A. used.
[その他のモノマー]
本発明で用いる重合性化合物は、本発明の効果を損なわない限り、前記モノマーA、モノマーBに属さない、その他のモノマーを含んでもいてもよい。
その他のモノマーとしては、分子内に1個のラジカル重合性二重結合を有するモノマーであれば特に制限はないが、ビニル化合物又は(メタ)アクリレート化合物であることが好ましい。[Other monomers]
The polymerizable compound used in the present invention may include other monomers that do not belong to the monomers A and B as long as the effects of the present invention are not impaired.
The other monomer is not particularly limited as long as it has one radical polymerizable double bond in the molecule, but is preferably a vinyl compound or a (meth) acrylate compound.
[オキシアルキレン部位]
前記式[1]におけるR1が表す炭素原子数1乃至6のアルキル基としては、例えば、メチル基、エチル基、n−プロピル基、イソプロピル基、n−ブチル基、イソブチル基、sec−ブチル基、tert−ブチル基、n−ペンチル基、イソアミル基、ネオペンチル基、tert−アミル基、sec−イソアミル基、シクロペンチル基、n−ヘキシル基、シクロヘキシル基等が挙げられる。これらの中でも、炭素原子数1乃至4のアルキル基が好ましく、特にメチル基、エチル基、n−プロピル基、n−ブチル基が好ましく、メチル基、エチル基がより好ましい。
また、L1が表す炭素原子数2乃至6のアルキレン基としては、例えば、エチレン基、トリメチレン基、メチルエチレン基、テトラメチレン基、1−メチルトリメチレン基、ペンタメチレン基、2,2−ジメチルトリメチレン基、ヘキサメチレン基等が挙げられる。これらの中でも、生体分子吸着抑制効果の観点から、エチレン基が好ましい。[Oxyalkylene moiety]
Examples of the alkyl group having 1 to 6 carbon atoms represented by R 1 in the formula [1] include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, and a sec-butyl group. Tert-butyl group, n-pentyl group, isoamyl group, neopentyl group, tert-amyl group, sec-isoamyl group, cyclopentyl group, n-hexyl group, cyclohexyl group and the like. Among these, an alkyl group having 1 to 4 carbon atoms is preferable, and a methyl group, an ethyl group, an n-propyl group, and an n-butyl group are particularly preferable, and a methyl group and an ethyl group are more preferable.
Examples of the alkylene group having 2 to 6 carbon atoms represented by L 1 include an ethylene group, a trimethylene group, a methylethylene group, a tetramethylene group, a 1-methyltrimethylene group, a pentamethylene group, and a 2,2-dimethyl group. Examples include a trimethylene group and a hexamethylene group. Among these, an ethylene group is preferable from the viewpoint of a biomolecule adsorption suppression effect.
[重合性化合物の重合方法]
前述のモノマーAと、モノマーBとを少なくとも含む重合性化合物を、該モノマーAに対して所定量の重合開始剤Cの存在下で重合させる重合方法としては公知の方法、例えば溶液重合、分散重合、沈殿重合、及び塊状重合等が挙げられ、中でも溶液重合又は沈殿重合が好ましい。特に分子量制御の点から、有機溶媒中での溶液重合によって反応を実施することが好ましい。[Method of polymerizing polymerizable compound]
Known polymerization methods for polymerizing a polymerizable compound containing at least the monomer A and the monomer B in the presence of a predetermined amount of the polymerization initiator C with respect to the monomer A, such as solution polymerization and dispersion polymerization , Precipitation polymerization, and bulk polymerization. Among them, solution polymerization or precipitation polymerization is preferable. In particular, from the viewpoint of controlling the molecular weight, it is preferable to carry out the reaction by solution polymerization in an organic solvent.
このとき用いられる有機溶媒としては、ベンゼン、トルエン、キシレン、エチルベンゼン、テトラリン等の芳香族炭化水素類;n−ヘキサン、n−ヘプタン、ミネラルスピリット、シクロヘキサン等の脂肪族又は脂環式炭化水素類;塩化メチル、臭化メチル、ヨウ化メチル、ジクロロメタン、クロロホルム、四塩化炭素、トリクロロエチレン、パークロロエチレン、オルトジクロロベンゼン等のハロゲン化物類;酢酸エチル、酢酸ブチル、メトキシブチルアセテート、メチルセロソルブアセテート、エチルセロソルブアセテート、プロピレングリコールモノメチルエーテルアセテート等のエステル類又はエステルエーテル類;ジエチルエーテル、テトラヒドロフラン、1,4−ジオキサン、メチルセロソルブ、エチルセロソルブ、ブチルセロソルブ、プロピレングリコールモノメチルエーテル等のエーテル類;アセトン、メチルエチルケトン、メチルイソブチルケトン、ジ−n−ブチルケトン、シクロヘキサノン等のケトン類;メタノール、エタノール、n−プロパノール、2−プロパノール、n−ブタノール、2−ブタノール、tert−ブチルアルコール、2−エチルヘキシルアルコール、ベンジルアルコール、エチレングリコール等のアルコール類;N,N−ジメチルホルムアミド、N,N−ジメチルアセトアミド、N−メチル−2−ピロリドン等のアミド類;ジメチルスルホキシド等のスルホキシド類、並びにこれらの2種以上の混合溶媒が挙げられる。 Examples of the organic solvent used at this time include aromatic hydrocarbons such as benzene, toluene, xylene, ethylbenzene, and tetralin; aliphatic or alicyclic hydrocarbons such as n-hexane, n-heptane, mineral spirit, and cyclohexane; Halides such as methyl chloride, methyl bromide, methyl iodide, dichloromethane, chloroform, carbon tetrachloride, trichloroethylene, perchloroethylene, orthodichlorobenzene; ethyl acetate, butyl acetate, methoxybutyl acetate, methyl cellosolve acetate, ethyl cellosolve Ester or ester ether such as acetate, propylene glycol monomethyl ether acetate; diethyl ether, tetrahydrofuran, 1,4-dioxane, methyl cellosolve, ethyl cellosolve, butyl cello Ethers such as rub and propylene glycol monomethyl ether; ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, di-n-butyl ketone and cyclohexanone; methanol, ethanol, n-propanol, 2-propanol, n-butanol and 2-butanol Alcohols such as tert-butyl alcohol, 2-ethylhexyl alcohol, benzyl alcohol and ethylene glycol; amides such as N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl-2-pyrrolidone; dimethyl sulfoxide and the like And a mixed solvent of two or more of these.
これらのうち好ましいのは、芳香族炭化水素類、ハロゲン化物類、エステル類、エステルエーテル類、エーテル類、ケトン類、アルコール類、アミド類等であり、特に好ましいものはベンゼン、トルエン、キシレン、オルトジクロロベンゼン、酢酸エチル、酢酸ブチル、プロピレングリコールモノメチルエーテルアセテート、プロピレングリコールモノメチルエーテル、テトラヒドロフラン、1,4−ジオキサン、メチルエチルケトン、メチルイソブチルケトン、メタノール、エタノール、n−プロパノール、2−プロパノール、n−ブタノール、2−ブタノール、tert−ブチルアルコール、N,N−ジメチルホルムアミド、N,N−ジメチルアセトアミド、N−メチル−2−ピロリドン等である。 Among these, preferred are aromatic hydrocarbons, halides, esters, ester ethers, ethers, ketones, alcohols, amides, and the like, and particularly preferred are benzene, toluene, xylene, and ortho. Dichlorobenzene, ethyl acetate, butyl acetate, propylene glycol monomethyl ether acetate, propylene glycol monomethyl ether, tetrahydrofuran, 1,4-dioxane, methyl ethyl ketone, methyl isobutyl ketone, methanol, ethanol, n-propanol, 2-propanol, n-butanol, 2-butanol, tert-butyl alcohol, N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl-2-pyrrolidone and the like.
上記重合反応を有機溶媒の存在下で行う場合、前記モノマーAの1質量部に対する前記有機溶媒の質量は、通常5〜120質量部であり、好ましくは10〜110質量部である。
重合反応は常圧、加圧密閉下、又は減圧下で行われ、装置及び操作の簡便さから常圧下で行うのが好ましい。また、N2等の不活性ガス雰囲気下で行うのが好ましい。
重合温度は、反応混合物の沸点以下であれば任意であるが、重合効率と分子量調節の点から、好ましくは50〜200℃であり、さらに好ましくは80〜150℃であり、80〜130℃がより好ましい。
反応時間は、反応温度や、モノマーA、モノマーB及び重合開始剤Cの種類及び割合、重合溶媒種等によって変動するものであるため一概には規定できないが、好ましくは30〜720分、より好ましくは40〜540分である。
重合反応の終了後、得られた含フッ素高分岐ポリマーを任意の方法で回収し、必要に応じて洗浄等の後処理を行う。反応溶液から高分子を回収する方法としては、再沈殿等の方法が挙げられる。When the above polymerization reaction is performed in the presence of an organic solvent, the mass of the organic solvent is usually 5 to 120 parts by mass, preferably 10 to 110 parts by mass with respect to 1 part by mass of the monomer A.
The polymerization reaction is carried out under normal pressure, under pressure or under reduced pressure, or under reduced pressure. Further, it is preferable to perform the treatment under an atmosphere of an inert gas such as N 2 .
The polymerization temperature is optional as long as it is equal to or lower than the boiling point of the reaction mixture, but is preferably from 50 to 200 ° C, more preferably from 80 to 150 ° C, and from 80 to 130 ° C, from the viewpoint of polymerization efficiency and molecular weight control. More preferred.
The reaction time cannot be specified unequivocally because it varies depending on the reaction temperature, the type and ratio of the monomer A, the monomer B and the polymerization initiator C, the type of the polymerization solvent, and the like, but is preferably 30 to 720 minutes, more preferably. Is 40 to 540 minutes.
After the completion of the polymerization reaction, the obtained fluorine-containing hyperbranched polymer is recovered by an optional method, and post-treatment such as washing is performed as necessary. Examples of a method for recovering the polymer from the reaction solution include a method such as reprecipitation.
なお本発明の含フッ素高分岐ポリマーのゲル浸透クロマトグラフィーによるポリスチレン換算で測定される重量平均分子量(Mw)は、1,000〜400,000、好ましくは2,000〜200,000、より好ましくは2,000〜100,000、ことさら好ましくは2,000〜50,000である。 The weight average molecular weight (Mw) of the fluorinated hyperbranched polymer of the present invention measured by gel permeation chromatography in terms of polystyrene is from 1,000 to 400,000, preferably from 2,000 to 200,000, more preferably from 2,000 to 200,000. It is 2,000 to 100,000, more preferably 2,000 to 50,000.
<含フッ素高分岐ポリマーの製造方法>
本発明の含フッ素高分岐ポリマーは、その分子末端に前記式[1]で表されるオキシアルキレン部位を有する。
オキシアルキレン部位の導入は、上記含フッ素高分岐ポリマーの前駆体といえるカルボキシ基含有含フッ素高分岐ポリマー又はそのカルボキシ基活性化体と、上記式[3]で表される化合物(ポリアルキレングリコールモノアルキルエーテル)とを反応させることにより得られる。
なお本製造方法もまた本発明の対象である。<Production method of fluorine-containing hyperbranched polymer>
The fluorinated hyperbranched polymer of the present invention has an oxyalkylene moiety represented by the above formula [1] at the molecular terminal.
The introduction of the oxyalkylene moiety is carried out by introducing a carboxy group-containing fluorinated hyperbranched polymer which can be said to be a precursor of the fluorinated hyperbranched polymer or a carboxyl group activated body thereof, and a compound represented by the above formula [3] (polyalkylene glycol mono- Alkyl ether).
This manufacturing method is also an object of the present invention.
前記カルボキシ基含有含フッ素高分岐ポリマーは、分子内に2個以上のラジカル重合性二重結合を有するモノマーAと、分子内にフルオロアルキル基及び少なくとも1個のラジカル重合性二重結合を有するモノマーBとを少なくとも含む重合性化合物を、該モノマーAのモル数に対して5〜200モル%の分子内にカルボキシ基を有する重合開始剤の存在下で重合させることにより得られるポリマーである。
また、そのカルボキシ基活性化体とは、前記カルボキシ基含有含フッ素高分岐ポリマーを、公知の活性エステル化剤と反応させることにより、該カルボキシ基の一部又は全部を活性エステル化させてなるポリマーである。前記公知の活性エステル化剤としては、ニトロフェノール、ペンタフルオロフェノール、N−ヒドロキシコハク酸イミド等が挙げられる。The carboxy group-containing fluorinated hyperbranched polymer includes a monomer A having two or more radical polymerizable double bonds in a molecule and a monomer having a fluoroalkyl group and at least one radical polymerizable double bond in a molecule. B is a polymer obtained by polymerizing a polymerizable compound containing at least B in the presence of a polymerization initiator having a carboxy group in a molecule of 5 to 200 mol% based on the number of moles of the monomer A.
The activated carboxy group is a polymer obtained by reacting the carboxy group-containing highly branched polymer containing carboxy group with a known active esterifying agent to partially or entirely activate the carboxy group. It is. Examples of the known active esterifying agent include nitrophenol, pentafluorophenol, N-hydroxysuccinimide and the like.
上記カルボキシ基含有含フッ素高分岐ポリマーは、前述の[重合性化合物の重合方法]に記載の方法を用いて製造可能であり、上記モノマーA及びモノマーBとしては、前述の[モノマーA][モノマーB]に記載のモノマーA、モノマーBを、また上記重合開始剤としては、前述の[重合開始剤C]のうち、4,4’−アゾビス(4−シアノバレリン酸)等のカルボキシ基を有する重合開始剤を好適に使用可能である。また、モノマーA及びモノマーBの他に、前述の[その他モノマー]を重合性化合物として併用してもよい。 The carboxy group-containing fluorine-containing hyperbranched polymer can be produced by the method described in the above-mentioned [Method for polymerizing polymerizable compound], and the above-mentioned [A] B] and monomers having a carboxy group such as 4,4′-azobis (4-cyanovaleric acid) among the above-mentioned polymerization initiators C as the polymerization initiator. Initiators can be suitably used. In addition to the monomers A and B, the above-mentioned [other monomers] may be used in combination as a polymerizable compound.
上記カルボキシ基含有含フッ素高分岐ポリマーのカルボキシ基活性化体を用いる場合、前記カルボキシ基含有含フッ素高分岐ポリマーと、前記公知の活性エステル化剤とを、これら化合物を溶解可能な溶媒中で反応させて、該含フッ素高分岐ポリマーのカルボキシ基の一部又は全部に活性エステル化剤を結合させ、カルボキシ基活性化体を得る。前記溶媒としては、例えば前述の[重合性化合物の重合方法]に用いる溶媒を挙げることができる。
上記反応において、活性エステル化剤の使用量は、該カルボキシ基含有含フッ素高分岐ポリマーのカルボキシ基量に対して、例えば、0.1〜10モル倍量である。活性エステル化剤の使用量を変更することで、全カルボキシ基に対する活性化カルボキシ基の割合を調節することができる。
上記反応は常圧、加圧密閉下、又は減圧下で行われ、装置及び操作の簡便さから常圧下で行うのが好ましい。また、N2等の不活性ガス雰囲気下で行うのが好ましい。
このとき、反応温度は−80〜200℃、好ましくは0〜100℃、より好ましくは10〜50℃にて行うことが望ましく、反応時間は0.1〜48時間、好ましくは0.2〜40時間にて行うことが望ましい。
反応終了後、得られたカルボキシ基活性体を任意の方法で回収し、必要に応じて洗浄等の後処理を行い、続く工程に使用する。反応溶液から回収する方法としては、再沈殿等の方法が挙げられる。When using the activated carboxy group of the carboxy group-containing highly branched fluorinated polymer, the carboxy group-containing highly branched fluorinated polymer is reacted with the known active esterifying agent in a solvent capable of dissolving these compounds. Then, an active esterifying agent is bonded to a part or all of the carboxy groups of the fluorinated hyperbranched polymer to obtain an activated carboxy group. Examples of the solvent include the solvents used in the above-mentioned [method of polymerizing a polymerizable compound].
In the above-mentioned reaction, the amount of the active esterifying agent used is, for example, 0.1 to 10 times the molar amount of the carboxy group of the carboxy group-containing fluorinated hyperbranched polymer. By changing the amount of the active esterifying agent used, the ratio of the activated carboxy groups to all the carboxy groups can be adjusted.
The above reaction is carried out under normal pressure, under pressure or under reduced pressure, and is preferably carried out under normal pressure in view of simplicity of the apparatus and operation. Further, it is preferable to perform the treatment under an atmosphere of an inert gas such as N 2 .
At this time, the reaction temperature is preferably −80 to 200 ° C., preferably 0 to 100 ° C., more preferably 10 to 50 ° C., and the reaction time is 0.1 to 48 hours, preferably 0.2 to 40 hours. It is desirable to perform in time.
After completion of the reaction, the obtained activated carboxy group is recovered by an optional method, and after-treatment such as washing is performed, if necessary, and used in the subsequent step. Examples of a method for recovering from the reaction solution include a method such as reprecipitation.
上記カルボキシ基含有含フッ素高分岐ポリマー又はそのカルボキシ基活性化体と、上記式[3]で表される化合物との反応は、公知の縮合剤の存在下で、これら化合物を溶解可能な溶媒中で実施される。前記溶媒としては、例えば前述の[重合性化合物の重合方法]に用いる溶媒を用いることができる。 The reaction between the carboxy group-containing fluorine-containing hyperbranched polymer or its activated carboxy group and the compound represented by the formula [3] is carried out in a solvent capable of dissolving these compounds in the presence of a known condensing agent. Will be implemented. As the solvent, for example, the solvent used in the above-mentioned [Method of polymerizing polymerizable compound] can be used.
上記式[3]で表される化合物において、式中のR1及びL1としては、前述の[オキシアルキレン部位]に示す基を挙げることができる。
上記式[3]で表される化合物としては特に限定されないが、中でも式中、nが3以上の整数を表す化合物であることが好ましい。また、得られる含フッ素高分岐ポリマーの特性の観点から、nが45以下の整数を表す化合物であることが好ましい。さらに、nが5以上45以下の整数を表す化合物、nが10以上45以下の整数を表す化合物、nが5以上30以下の整数を表す化合物、又はnが10以上30以下の整数を表す化合物であることが好ましい。
式[3]で表される化合物としては、例えば、エチレングリコールモノメチルエーテル、ジエチレングリコールモノメチルエーテル、ジエチレングリコールモノブチルエーテル、トリエチレングリコールモノメチルエーテル、トリエチレングリコールモノエチルエーテル、テトラエチレングリコールモノメチルエーテル、ヘプタエチレングリコールモノメチルエーテル、ヘキサエチレングリコールモノメチルエーテル、ノナエチレングリコールモノメチルエーテル、ドデカエチレングリコールモノエチルエーテル、トリデカエチレングリコールモノメチルエーテル、テトラデカエチレングリコールモノメチルエーテル、ポリエチレングリコールモノメチルエーテル、ジプロピレングリコールモノメチルエーテル、トリプロピレングリコールモノメチルエーテル、ヘプタプロピレングリコールモノメチルエーテル、トリ(テトラメチレングリコール)モノメチルエーテル、ノナ(テトラメチレングリコール)モノメチルエーテル、ポリ(テトラメチレングリコール)モノメチルエーテル等が挙げられる。中でも、トリエチレングリコールモノメチルエーテル、トリエチレングリコールモノエチルエーテル、ヘキサエチレングリコールモノメチルエーテル、ドデカエチレングリコールモノメチルエーテル、ポリエチレングリコールモノメチルエーテル等を好適に使用可能である。In the compound represented by the above formula [3], as R 1 and L 1 in the formula, the groups represented by the aforementioned [oxyalkylene moiety] can be exemplified.
The compound represented by the formula [3] is not particularly limited, but is preferably a compound in which n represents an integer of 3 or more. Further, from the viewpoint of the properties of the obtained fluorine-containing hyperbranched polymer, it is preferable that n is an integer of 45 or less. Further, a compound in which n is an integer of 5 to 45, a compound in which n is an integer in the range of 10 to 45, a compound in which n is an integer of 5 to 30 or a compound in which n is an integer of 10 to 30 It is preferred that
Examples of the compound represented by the formula [3] include ethylene glycol monomethyl ether, diethylene glycol monomethyl ether, diethylene glycol monobutyl ether, triethylene glycol monomethyl ether, triethylene glycol monoethyl ether, tetraethylene glycol monomethyl ether, and heptaethylene glycol monomethyl. Ether, hexaethylene glycol monomethyl ether, nonaethylene glycol monomethyl ether, dodecaethylene glycol monoethyl ether, tridecaethylene glycol monomethyl ether, tetradecaethylene glycol monomethyl ether, polyethylene glycol monomethyl ether, dipropylene glycol monomethyl ether, tripropylene glycol Methyl ether, hepta propylene glycol monomethyl ether, tri (tetramethylene glycol) monomethyl ether, nona (tetramethylene glycol) monomethyl ether, poly (tetramethylene glycol) monomethyl ether, and the like. Among them, triethylene glycol monomethyl ether, triethylene glycol monoethyl ether, hexaethylene glycol monomethyl ether, dodecaethylene glycol monomethyl ether, polyethylene glycol monomethyl ether and the like can be preferably used.
上記の公知の縮合剤としては、N,N’−ジシクロヘキシルカルボジイミド(DCC)、N,N’−ジイソプロピルカルボジイミド(DIC)、1−エチル−3−(3−ジメチルアミノプロピル)カルボジイミド(EDC)塩酸塩等のカルボジイミド類、N,N’−カルボニルジイミダゾール、ジメシチルアンモニウムペンタフルオロベンゼンスルホナート等が挙げられる。なお、DCC等のカルボジイミド類を用いる場合、触媒量の4−ジメチルアミノピリジン(DMAP)を併用することが好ましい。
上記反応は常圧、加圧密閉下、又は減圧下で行われ、装置及び操作の簡便さから常圧下で行うのが好ましい。また、N2等の不活性ガス雰囲気下で行うのが好ましい。
このとき、反応温度は−80〜200℃、好ましくは0〜100℃、より好ましくは10〜50℃にて行うことが望ましく、反応時間は0.1〜48時間、好ましくは0.2〜40時間にて行うことが望ましい。
上記反応の終了後、得られた高分岐ポリマー(分子末端に前記式[1]で表されるオキシアルキレン部位を有する含フッ素高分岐ポリマー)を任意の方法で回収し、必要に応じて洗浄等の後処理を行う。反応溶液から高分子を回収する方法としては、再沈殿等の方法が挙げられる。Examples of the known condensing agent include N, N′-dicyclohexylcarbodiimide (DCC), N, N′-diisopropylcarbodiimide (DIC), 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide (EDC) hydrochloride And the like, N, N'-carbonyldiimidazole, dimesitylammonium pentafluorobenzenesulfonate and the like. When using carbodiimides such as DCC, it is preferable to use a catalytic amount of 4-dimethylaminopyridine (DMAP) in combination.
The above reaction is carried out under normal pressure, under pressure or under reduced pressure, and is preferably carried out under normal pressure in view of simplicity of the apparatus and operation. Further, it is preferable to perform the treatment under an atmosphere of an inert gas such as N 2 .
At this time, the reaction temperature is preferably −80 to 200 ° C., preferably 0 to 100 ° C., more preferably 10 to 50 ° C., and the reaction time is 0.1 to 48 hours, preferably 0.2 to 40 hours. It is desirable to perform in time.
After the completion of the above reaction, the obtained hyperbranched polymer (fluorinated hyperbranched polymer having an oxyalkylene moiety represented by the above formula [1] at the molecular terminal) is recovered by any method, and if necessary, washed or the like. Perform post-processing. Examples of a method for recovering the polymer from the reaction solution include a method such as reprecipitation.
<含フッ素高分岐ポリマーを含有するワニス及び薄膜の製造方法>
本発明の含フッ素高分岐ポリマーより作製される薄膜(生体分子吸着抑制作用を有する薄膜)を形成する具体的な方法としては、まず、含フッ素高分岐ポリマーを溶媒に溶解又は分散してワニスの形態(膜形成材料)とし、該ワニスを基材上にキャストコート法、スピンコート法、ブレードコート法、ディップコート法、ロールコート法、バーコート法、ダイコート法、スプレーコート法、インクジェット法、印刷法(凸版、凹版、平版、スクリーン印刷等)等によって塗布し、その後、ホットプレート又はオーブン等で乾燥して製膜する。
これらの塗布方法の中でもスピンコート法が好ましい。スピンコート法を用いる場合には、単時間で塗布することができるために、揮発性の高い溶液であっても利用でき、また、均一性の高い塗布を行うことができるという利点がある。<Method for producing varnish and thin film containing fluorine-containing hyperbranched polymer>
As a specific method for forming a thin film (a thin film having a biomolecule adsorption suppressing action) produced from the fluorinated hyperbranched polymer of the present invention, first, the fluorinated hyperbranched polymer is dissolved or dispersed in a solvent to prepare a varnish. In the form (film forming material), the varnish is cast on a substrate by a cast coating method, a spin coating method, a blade coating method, a dip coating method, a roll coating method, a bar coating method, a die coating method, a spray coating method, an ink jet method, and printing. It is applied by a method such as letterpress, intaglio, lithographic, or screen printing, and then dried on a hot plate or oven to form a film.
Among these coating methods, spin coating is preferred. In the case of using the spin coating method, since the coating can be performed in a single time, there is an advantage that a highly volatile solution can be used and the coating can be performed with high uniformity.
上記ワニスの形態において使用する溶媒としては、上記含フッ素高分岐ポリマーを溶解するものであればよく、例えば、メタノール、アセトン、テトラヒドロフラン(THF)、トルエン、N,N−ジメチルホルムアミド(DMF)、シクロヘキサノン、プロピレングリコールモノメチルエーテル(PGME)、プロピレングリコールモノメチルエーテルアセテート(PGMEA)、プロピレングリコールモノエチルエーテル、乳酸エチル、ジエチレングリコールモノエチルエーテル、ブチルセロソルブ、γ−ブチロラクトン等が挙げられる。これら溶媒は単独で使用してもよく、2種類以上の溶媒を混合してもよい。
また上記溶媒に溶解又は分散させる濃度は任意であるが、含フッ素高分岐ポリマーと溶媒の総質量(合計質量)に対して、含フッ素高分岐ポリマーの濃度は0.01〜90質量%であり、好ましくは0.05〜50質量%であり、より好ましくは0.1〜20質量%である。The solvent used in the form of the varnish may be any solvent that dissolves the above-mentioned fluorine-containing hyperbranched polymer, and examples thereof include methanol, acetone, tetrahydrofuran (THF), toluene, N, N-dimethylformamide (DMF), and cyclohexanone. Propylene glycol monomethyl ether (PGME), propylene glycol monomethyl ether acetate (PGMEA), propylene glycol monoethyl ether, ethyl lactate, diethylene glycol monoethyl ether, butyl cellosolve, γ-butyrolactone, and the like. These solvents may be used alone, or two or more solvents may be mixed.
The concentration of the fluorinated hyperbranched polymer is 0.01 to 90% by mass based on the total mass (total mass) of the fluorinated hyperbranched polymer and the solvent. , Preferably 0.05 to 50% by mass, more preferably 0.1 to 20% by mass.
形成された含フッ素高分岐ポリマーからなる薄膜の厚さは特に限定されないが、通常0.005〜50μm、好ましくは0.01〜20μmである。 Although the thickness of the formed thin film made of the fluorine-containing hyperbranched polymer is not particularly limited, it is usually 0.005 to 50 μm, preferably 0.01 to 20 μm.
<含フッ素高分岐ポリマーを含有する樹脂ブレンド>
本発明はまた、前述の(a)含フッ素高分岐ポリマー、及び(b)熱可塑性樹脂を含む樹脂ブレンドに関する。<Resin blend containing fluorine-containing hyperbranched polymer>
The present invention also relates to a resin blend containing (a) the above-mentioned highly branched fluorine-containing polymer and (b) a thermoplastic resin.
[熱可塑性樹脂]
本発明の樹脂ブレンドに含まれる熱可塑性樹脂は特に限定されないが、例えばPE(ポリエチレン)、PP(ポリプロピレン)、EVA(エチレン−酢酸ビニル共重合体)、EEA(エチレン−アクリル酸エチル共重合体)などのポリオレフィン系樹脂;PS(ポリスチレン)、HIPS(ハイインパクトポリスチレン)、AS(アクリロニトリル−スチレン共重合体)、ABS(アクリロニトリル−ブタジエン−スチレン共重合体)、MS(メタクリル酸メチル−スチレン共重合体)などのポリスチレン系樹脂;ポリカーボネート樹脂;塩化ビニル樹脂;ポリアミド樹脂;ポリイミド樹脂;PMMA(ポリメタクリル酸メチル)などの(メタ)アクリル樹脂;PET(ポリエチレンテレフタレート)、ポリブチレンテレフタレート、ポリエチレンナフタレート、ポリブチレンナフタレート、PLA(ポリ乳酸)、ポリ−3−ヒドロキシ酪酸、ポリカプロラクトン、ポリブチレンサクシネート、ポリエチレンサクシネート/アジペートなどのポリエステル樹脂;ポリフェニレンエーテル樹脂;変性ポリフェニレンエーテル樹脂;ポリアセタール樹脂;ポリスルホン樹脂;ポリフェニレンスルフィド樹脂;ポリビニルアルコール樹脂;ポリグルコール酸;変性でんぷん;酢酸セルロース、三酢酸セルロース;キチン、キトサン;リグニン等が挙げられる。
中でも、ポリスチレン系樹脂又は(メタ)アクリル樹脂であることが好ましく、特にポリスチレン樹脂又はポリメタクリル酸メチル樹脂であることが好ましい。[Thermoplastic resin]
Although the thermoplastic resin contained in the resin blend of the present invention is not particularly limited, for example, PE (polyethylene), PP (polypropylene), EVA (ethylene-vinyl acetate copolymer), EEA (ethylene-ethyl acrylate copolymer) PS (polystyrene), HIPS (high impact polystyrene), AS (acrylonitrile-styrene copolymer), ABS (acrylonitrile-butadiene-styrene copolymer), MS (methyl methacrylate-styrene copolymer) Polycarbonate resin; Polyvinyl chloride resin; Polyamide resin; Polyimide resin; (Meth) acrylic resin such as PMMA (Polymethyl methacrylate); PET (Polyethylene terephthalate), Polybutylene terephthalate, Polyethylene resin Polyester resins such as lennaphthalate, polybutylene naphthalate, PLA (polylactic acid), poly-3-hydroxybutyric acid, polycaprolactone, polybutylene succinate, polyethylene succinate / adipate; polyphenylene ether resin; modified polyphenylene ether resin; polyacetal resin Polysulfone resin; polyphenylene sulfide resin; polyvinyl alcohol resin; polyglycolic acid; modified starch; cellulose acetate, cellulose triacetate; chitin, chitosan;
Among them, a polystyrene resin or a (meth) acrylic resin is preferable, and a polystyrene resin or a polymethyl methacrylate resin is particularly preferable.
上記樹脂ブレンドにおいて、熱可塑性樹脂に対する含フッ素高分岐ポリマーの配合量は、好ましくは0.01〜50質量%であり、特に0.1〜40質量%であることが好ましい。 In the above resin blend, the blending amount of the fluorine-containing hyperbranched polymer with respect to the thermoplastic resin is preferably 0.01 to 50% by mass, and particularly preferably 0.1 to 40% by mass.
<樹脂ブレンドより作製される生体分子吸着抑制膜及びその形成法>
本発明の樹脂ブレンドは、該樹脂ブレンドを溶媒に溶解又は分散してワニスの形態(膜形成材料)とし、該ワニスを基材上に塗布(コーティング)することにより、生体分子吸着抑制膜、さらには成形体を形成できる。
前記基材上への塗布方法は、キャストコート法、スピンコート法、ブレードコート法、ディップコート法、ロールコート法、バーコート法、ダイコート法、スプレーコート法、インクジェット法、印刷法(凸版、凹版、平版、スクリーン印刷等)等を適宜選択し得、中でも短時間で塗布できることから揮発性の高い溶液であっても利用でき、また、均一性の高い塗布を行うことができるという利点より、スピンコート法を用いることが望ましい。なお事前に孔径が0.2μm程度のフィルタなどを用いて樹脂ブレンドを濾過した後、塗布に供することが好ましい。<Biomolecule adsorption suppression film produced from resin blend and method for forming the same>
The resin blend of the present invention is obtained by dissolving or dispersing the resin blend in a solvent to form a varnish (film-forming material), and applying (coating) the varnish on a base material to form a biomolecule adsorption suppressing film. Can form a molded article.
The coating method on the base material includes a cast coating method, a spin coating method, a blade coating method, a dip coating method, a roll coating method, a bar coating method, a die coating method, a spray coating method, an inkjet method, and a printing method (letter plate, intaglio plate). , Lithography, screen printing, etc.) can be appropriately selected. Among them, spin-coating can be used because it can be applied even in a highly volatile solution because it can be applied in a short time, and spin-coating can be performed with high uniformity. It is desirable to use a coating method. It is preferable that the resin blend is filtered using a filter having a pore diameter of about 0.2 μm or the like in advance, and then subjected to coating.
上記ワニスの形態において使用する溶媒としては、上記樹脂ブレンドを溶解するものであればよく、これら溶媒の具体例としては、前記<含フッ素高分岐ポリマーを含有するワニス及び薄膜の製造方法>に挙げた溶媒と同じものが挙げられる。
上記ワニスにおける固形分は、例えば0.01〜50質量%、0.05〜30質量%、又は0.1〜20質量%である。ここで固形分とはワニスの全成分から溶媒成分を除いたものである。The solvent used in the form of the varnish may be any solvent capable of dissolving the resin blend, and specific examples of these solvents are described in the above <Method for producing varnish and thin film containing fluorine-containing hyperbranched polymer>. And the same solvents as those described above.
The solid content in the varnish is, for example, 0.01 to 50% by mass, 0.05 to 30% by mass, or 0.1 to 20% by mass. Here, the solid content is a value obtained by removing the solvent component from all components of the varnish.
前記基材としては、例えば、シリコン/二酸化シリコン被覆基板、シリコンウエハ、シリコンナイトライド基板、ガラス基板、ITO基板、プラスチック基板(ポリイミド、ポリカーボネート、ポリメタクリレート、ポリスチレン、ポリエステル、ポリオレフィン、エポキシ、メラミン、トリアセチルセルロース、ABS、AS、ノルボルネン系樹脂等)、金属、木材、紙、ガラス、スレート等を挙げることができる。これら基材の形状は板状、フィルム状又は3次元成形体でもよい。 Examples of the substrate include a silicon / silicon dioxide-coated substrate, a silicon wafer, a silicon nitride substrate, a glass substrate, an ITO substrate, and a plastic substrate (polyimide, polycarbonate, polymethacrylate, polystyrene, polyester, polyolefin, epoxy, melamine, triamine, etc.). Acetylcellulose, ABS, AS, norbornene-based resin, etc.), metal, wood, paper, glass, slate and the like. The shape of these substrates may be plate-like, film-like or three-dimensionally formed.
塗布後、必要であれば続いてホットプレート又はオーブン等で乾燥し、溶媒を除去する。この時の乾燥温度及び乾燥時間は、使用する溶媒にもよるが、室温(およそ25℃)〜400℃、10秒間〜48時間の間で適宜選択可能である。 After the application, if necessary, it is subsequently dried on a hot plate or an oven to remove the solvent. The drying temperature and drying time at this time can be appropriately selected from room temperature (about 25 ° C.) to 400 ° C. for 10 seconds to 48 hours, depending on the solvent used.
溶媒を除去した塗膜は、続いて極性媒体の雰囲気下で、得られた塗膜のアニーリングを行うこと、所謂“溶媒アニーリング”を行ってもよい。
ここで用語「溶媒アニーリング(solvent annealing)」は、溶媒蒸気処理を指し、密閉容器中、室温又はさらに高い温度において、溶媒蒸気を含む空気に曝すことを指す。溶媒アニーリングは、一般に膜の表面状態を変化せしめることができ、本発明においては、膜表面の含フッ素高分岐ポリマーの存在量をより一層高めることができる。
本発明において、上記極性媒体(溶媒アニーリングに使用する溶媒)としては、メタノール、エタノールなどのアルコール類等が挙げられ、中でもメタノールが好ましい。
また、アニーリング時の温度及びアニーリング時間(溶媒蒸気に曝す時間)は特に限定されないが、例えば室温(およそ25℃)乃至使用溶媒の沸点、10秒間〜48時間の間で適宜選択可能である。The coating film from which the solvent has been removed may be subjected to annealing of the obtained coating film in an atmosphere of a polar medium, that is, so-called “solvent annealing”.
As used herein, the term "solvent annealing" refers to solvent vapor treatment and refers to exposure to air containing solvent vapor at room temperature or higher in a closed vessel. The solvent annealing can generally change the surface state of the film, and in the present invention, the amount of the fluorine-containing hyperbranched polymer on the film surface can be further increased.
In the present invention, examples of the polar medium (solvent used for solvent annealing) include alcohols such as methanol and ethanol, and among them, methanol is preferable.
The annealing temperature and annealing time (exposure time to the solvent vapor) are not particularly limited, but may be appropriately selected from, for example, room temperature (about 25 ° C.) to the boiling point of the solvent used, and 10 seconds to 48 hours.
なお、塗布による膜の厚さは、乾燥後、必要に応じてその後の溶媒アニーリング後において、通常0.005〜50μm、好ましくは0.01〜20μmである。 The thickness of the film by coating is usually 0.005 to 50 μm, preferably 0.01 to 20 μm after drying and, if necessary, after the subsequent solvent annealing.
以下、実施例を挙げて、本発明をより具体的に説明するが、本発明は下記の実施例に限定されるものではない。
なお、実施例において、試料の調製及び物性の分析に用いた装置及び条件は、以下の通りである。Hereinafter, the present invention will be described more specifically with reference to Examples, but the present invention is not limited to the following Examples.
In the examples, the devices and conditions used for sample preparation and physical property analysis are as follows.
(1)1H NMRスペクトル
装置:日本電子(株)製 JNM−ECA700(製造例1)
日本電子(株)製 JNM−ECP400(実施例1、5〜7)
溶媒:CDCl3(製造例1、実施例1)
(CD3)2C(=O)(実施例5〜7)
基準:CHCl3(7.26ppm)(製造例1)
テトラメチルシラン(0.00ppm)(実施例1)
(CH3)2C(=O)(2.10ppm)(実施例5〜7)
(2)13C NMRスペクトル
装置:BRUKER社製 AVANCE(登録商標)III 600
溶媒:CDCl3
基準ピーク:CDCl3(77.0ppm)
(3)ゲル浸透クロマトグラフィー(GPC)
装置:東ソー(株)製 HLC−8220GPC
カラム:昭和電工(株)製 Shodex(登録商標)GPC KF−804L、同KF−805L
カラム温度:40℃
溶媒:テトラヒドロフラン
検出器:RI
(4)IRスペクトル
装置:日本分光(株)製 FT/IR−620
測定条件:KBr錠法、室温、大気下
分解能:4cm−1
(5)スピンコーター
装置:ミカサ(株)製 1H−D7
(6)乾燥器
装置:(株)いすゞ製作所製 ISUZU−SVK−10S
(7)X線光電子分光測定(XPS)
装置:アルバック・ファイ(株)製 ESCA 5800
測定条件:14.0kV、14mA
中和条件:bias(V)6.00
Extractor(V)30
X=24.5
Y;角度により変更
(8)接触角
装置:協和界面科学(株)製 DropMaster 500
(9)蛍光顕微鏡
装置:株式会社キーエンス製 標準タイプBiozero蛍光顕微鏡BZ−8100シリーズ
フィルタ:BZフィルタTRITC
露光時間:2.5秒
励起波長:494nm
吸収波長:520nm
(10)走査電子顕微鏡(SEM)観察
装置:(株)島津製作所製 SS−550
加速電圧:15kV
倍率:×1500(1) 1 H NMR spectrum Apparatus: JNM-ECA700 manufactured by JEOL Ltd. (Production Example 1)
JNM-ECP400 manufactured by JEOL Ltd. (Examples 1, 5 to 7)
Solvent: CDCl 3 (Production Example 1, Example 1)
(CD 3) 2 C (= O) ( Example 5-7)
Standard: CHCl 3 (7.26 ppm) (Production Example 1)
Tetramethylsilane (0.00 ppm) (Example 1)
(CH 3) 2 C (= O) (2.10ppm) ( Example 5-7)
(2) 13 C NMR spectrum Apparatus: AVANCE (registered trademark) III 600 manufactured by Bruker
Solvent: CDCl 3
Reference peak: CDCl 3 (77.0 ppm)
(3) Gel permeation chromatography (GPC)
Apparatus: Tosoh Corporation HLC-8220GPC
Column: Showex (registered trademark) GPC KF-804L, KF-805L manufactured by Showa Denko KK
Column temperature: 40 ° C
Solvent: tetrahydrofuran Detector: RI
(4) IR spectrum Apparatus: FT / IR-620 manufactured by JASCO Corporation
Measurement conditions: KBr tablet method, room temperature, under air Resolution: 4 cm -1
(5) Spin coater: 1H-D7 manufactured by Mikasa Corporation
(6) Dryer device: ISUZU-SVK-10S manufactured by Isuzu Corporation
(7) X-ray photoelectron spectroscopy (XPS)
Apparatus: ESCA 5800 manufactured by ULVAC-PHI, Inc.
Measurement conditions: 14.0 kV, 14 mA
Neutralization condition: bias (V) 6.00
Extractor (V) 30
X = 24.5
Y: Change according to angle (8) Contact angle Device: DropMaster 500 manufactured by Kyowa Interface Science Co., Ltd.
(9) Fluorescence microscope Apparatus: Keyence Corporation Standard type Biozero fluorescence microscope BZ-8100 series Filter: BZ filter TRITC
Exposure time: 2.5 seconds Excitation wavelength: 494 nm
Absorption wavelength: 520 nm
(10) Scanning electron microscope (SEM) observation Apparatus: SS-550 manufactured by Shimadzu Corporation
Acceleration voltage: 15 kV
Magnification: × 1500
また、略記号は以下の意味を表す。
DVB:ジビニルベンゼン[新日鉄住金化学(株)製 DVB−960]
C6FA:2−(パーフルオロヘキシル)エチルアクリレート[ユニマテック(株)製 FAAC−6]
ACVA:4,4’−アゾビス(4−シアノバレリン酸)[和光純薬工業(株) V−501]
TEGMEE:トリエチレングリコールモノエチルエーテル[東京化成工業(株)製]
HEGMME:ヘキサエチレングリコールモノメチルエーテル[東京化成工業(株)製]
12EGME:ポリエチレングリコールモノメチルエーテル[Aldrich社製 製品番号:202487 数平均分子量:550]
45EGME:ポリエチレングリコールモノメチルエーテル[Aldrich社製 製品番号:202509 数平均分子量:〜2,000]
DCC:N,N’−ジシクロヘキシルカルボジイミド[東京化成工業(株)製]
DIC:N,N’−ジイソプロピルカルボジイミド[東京化成工業(株)製]
DMAP:4−(ジメチルアミノ)ピリジン[関東化学(株)製]
PMMA:ポリメタクリル酸メチル[Polymer Source社製 重量平均分子量:315,000]
EGME:エチレングリコールモノメチルエーテル
IPE:ジイソプロピルエーテル
THF:テトラヒドロフランThe abbreviations have the following meanings.
DVB: divinylbenzene [DVB-960, manufactured by Nippon Steel & Sumikin Chemical Co., Ltd.]
C6FA: 2- (perfluorohexyl) ethyl acrylate [FAAC-6 manufactured by Unimatec Co., Ltd.]
ACVA: 4,4'-azobis (4-cyanovaleric acid) [V-501, Wako Pure Chemical Industries, Ltd.]
TEGMEE: Triethylene glycol monoethyl ether [manufactured by Tokyo Chemical Industry Co., Ltd.]
HEGMME: Hexaethylene glycol monomethyl ether [manufactured by Tokyo Chemical Industry Co., Ltd.]
12EGME: polyethylene glycol monomethyl ether [manufactured by Aldrich, product number: 202487, number average molecular weight: 550]
45EGME: polyethylene glycol monomethyl ether [manufactured by Aldrich, product number: 202509 number average molecular weight: : 2,000]
DCC: N, N'-dicyclohexylcarbodiimide [manufactured by Tokyo Chemical Industry Co., Ltd.]
DIC: N, N'-diisopropylcarbodiimide [manufactured by Tokyo Chemical Industry Co., Ltd.]
DMAP: 4- (dimethylamino) pyridine [Kanto Chemical Co., Ltd.]
PMMA: Polymethyl methacrylate [Weight average molecular weight: 315,000, manufactured by Polymer Source Co.]
EGME: ethylene glycol monomethyl ether IPE: diisopropyl ether THF: tetrahydrofuran
[製造例1]末端にカルボキシ基を有する含フッ素高分岐ポリマー1の製造
1Lの反応フラスコに、EGME325gを仕込み、撹拌しながら5分間窒素を流し込み、内液が還流するまで(およそ125℃)加熱した。
別の500mLの反応フラスコに、モノマーAとしてDVB6.5g(50mmol)、モノマーBとしてC6FA10.5g(25mmol)、開始剤としてACVA14.0g(50mmol)、及びEGME325gを仕込み、撹拌しながら5間窒素を流し込み窒素置換を行った。
前述の1Lの反応フラスコ中の還流してあるEGME中に、DVB、C6FA及びACVAが仕込まれた前述の500mLの反応フラスコから、滴下ポンプを用いて、内容物を1時間かけて滴下した。滴下終了後、さらに1時間撹拌した。
次に、この反応液からロータリーエバポレーターを用いてEGME553gを留去後、その残渣をIPE650gに添加してポリマーをスラリー状態で沈殿させた。このスラリーを減圧ろ過し、白色粉末の粗物を得た。この粗物をTHF50gに再溶解させ、再度IPE650gに添加してポリマーを再沈殿した。さらに上記一連の操作(減圧ろ過−THFに再溶解−IPEで再沈殿)をもう一度繰返し精製した。最後に得られた沈殿物を減圧ろ過、真空乾燥して、白色粉末の目的物(末端にカルボキシ基を有する含フッ素高分岐ポリマー1)13.8gを得た。
得られた末端にカルボキシ基を有する含フッ素高分岐ポリマー1の1H NMRスペクトルを図1に、13C NMRスペクトルを図2にそれぞれ示す。13C NMRスペクトルから算出した、下記構造式に示す末端にカルボキシ基を有する含フッ素高分岐ポリマー1の単位構造組成(モル比)は、DVBユニット[A]:C6FAユニット[B]:ACVAユニット[C]=1.0:0.7:0.5であった。また、該ポリマーのGPCによるポリスチレン換算で測定される重量平均分子量Mwは9,500、分散度:Mw(重量平均分子量)/Mn(数平均分子量)は2.4であった。[Production Example 1] Production of fluorinated hyperbranched polymer 1 having a carboxy group at the end 325 g of EGME was charged into a 1 L reaction flask, and nitrogen was poured for 5 minutes with stirring, and the mixture was heated until the internal solution was refluxed (about 125 ° C). did.
Another 500 mL reaction flask was charged with 6.5 g (50 mmol) of DVB as monomer A, 10.5 g (25 mmol) of C6FA as monomer B, 14.0 g (50 mmol) of ACVA as an initiator, and 325 g of EGME. Pour nitrogen was performed.
The contents were dropped into the refluxed EGME in the 1 L reaction flask from the above 500 mL reaction flask charged with DVB, C6FA and ACVA using a dropping pump over 1 hour. After the completion of the dropwise addition, the mixture was further stirred for 1 hour.
Next, 553 g of EGME was distilled off from the reaction solution using a rotary evaporator, and the residue was added to 650 g of IPE to precipitate a polymer in a slurry state. This slurry was filtered under reduced pressure to obtain a white powder as a crude product. This crude product was redissolved in 50 g of THF and added again to 650 g of IPE to reprecipitate the polymer. Further, the above series of operations (reduced pressure filtration-redissolved in THF-reprecipitation with IPE) was repeated once and purified. Finally, the obtained precipitate was filtered under reduced pressure and dried under vacuum to obtain 13.8 g of the target substance (fluorine-containing highly branched polymer 1 having a carboxy group at a terminal) as a white powder.
The 1 H NMR spectrum and the 13 C NMR spectrum of the obtained fluorine-containing hyperbranched polymer 1 having a carboxy group at the terminal are shown in FIG. 1 and FIG. 2, respectively. The unit structural composition (molar ratio) of the fluorine-containing hyperbranched polymer 1 having a carboxy group at the terminal represented by the following structural formula, calculated from the 13 C NMR spectrum, is as follows: DVB unit [A]: C6FA unit [B]: ACVA unit [ C] = 1.0: 0.7: 0.5. The weight average molecular weight Mw of the polymer measured in terms of polystyrene by GPC was 9,500, and the degree of dispersion: Mw (weight average molecular weight) / Mn (number average molecular weight) was 2.4.
[実施例1]末端にトリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー2の製造
25mLの三口フラスコ、に製造例1で得られた末端にカルボキシ基を有する含フッ素高分岐ポリマー1 38mg(5.1μmol)、TEGMEE16mg(97μmol)、触媒としてDMAP7mg(57μmol)、縮合剤としてDCC21mg(100μmol)、及び予めCaH2で脱水したTHF2.7mgを仕込んだ。この溶液を窒素雰囲気下、室温(およそ20℃)で24時間撹拌し反応させた。析出したジシクロへキシルウレア(DCU)をろ過により除去した。THFを減圧留去し、得られた残渣をクロロホルムに溶解した。次に、この溶液をpH5の塩酸水溶液で3回洗浄しDMAPを除去した。さらに蒸留水で2回洗浄した後、無水硫酸ナトリウムで乾燥し、クロロホルムを減圧留去した。残渣をジエチルエーテルで3回洗浄することで白色粘稠体の目的物(末端にトリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー2)9mgを得た。
得られた末端にトリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー2のIRスペクトルを図3に、1H NMRスペクトルを図4にそれぞれ示す。また図3には、末端にカルボキシ基を有する含フッ素高分岐ポリマー1のIRスペクトルも合わせて示す。IRスペクトルにおいて、2800〜2500cm−1付近にカルボン酸のOH伸縮振動由来のブロードなピークが観測されなかったことから、含フッ素高分岐ポリマー1のほぼ全ての末端カルボキシ基に、トリ(エチレンオキシド)部位が導入されていることが確認された。Example 1 Production of Fluorine-Containing Hyperbranched Polymer 2 Having Tri (ethylene oxide) Portion at the Terminal In a 25 mL three-necked flask, 38 mg (5) of the fluorinated hyperbranched polymer having a carboxy group at the terminal obtained in Production Example 1 was added. 0.1 μmol), 16 mg (97 μmol) of TEGMEE, 7 mg (57 μmol) of DMAP as a catalyst, 21 mg (100 μmol) of DCC as a condensing agent, and 2.7 mg of THF previously dehydrated with CaH 2 . This solution was stirred and reacted at room temperature (about 20 ° C.) for 24 hours under a nitrogen atmosphere. The precipitated dicyclohexylurea (DCU) was removed by filtration. THF was distilled off under reduced pressure, and the obtained residue was dissolved in chloroform. Next, this solution was washed three times with an aqueous hydrochloric acid solution of pH 5 to remove DMAP. Further, after washing twice with distilled water, drying was performed with anhydrous sodium sulfate, and chloroform was distilled off under reduced pressure. The residue was washed three times with diethyl ether to obtain 9 mg of a white viscous target substance (fluorinated hyperbranched polymer 2 having a tri (ethylene oxide) moiety at a terminal).
FIG. 3 shows the IR spectrum of the obtained fluorinated hyperbranched polymer 2 having a tri (ethylene oxide) moiety at the terminal, and FIG. 4 shows the 1 H NMR spectrum thereof. FIG. 3 also shows the IR spectrum of the fluorinated hyperbranched polymer 1 having a carboxy group at the terminal. In the IR spectrum, a broad peak derived from the OH stretching vibration of the carboxylic acid was not observed around 2800 to 2500 cm −1 , so that a tri (ethylene oxide) site was added to almost all terminal carboxy groups of the fluorine-containing hyperbranched polymer 1. It was confirmed that was introduced.
[実施例5]末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー3(エチレンオキシドの繰返し単位数n=6)の製造
25mLの三口フラスコに、製造例1で得られた末端にカルボキシ基を有する含フッ素高分岐ポリマー1 200mg(21μmol)、HEGMME120mg(0.40mmol)、触媒としてDMAP27mg(0.22mmol)、縮合剤としてDIC60mg(0.48mmol)、及び予めCaH2で脱水したTHF1.3gを仕込んだ。この溶液を窒素雰囲気下、室温(およそ20℃)で120時間撹拌し反応させた。析出したジイソプロピルウレア(DIU)をろ過により除去した。THFを減圧留去し、得られた残渣をクロロホルムに溶解した。次に、この溶液をpH5の塩酸水溶液で3回洗浄しDMAPを除去した。さらに蒸留水で2回洗浄した後、無水硫酸ナトリウムで乾燥し、クロロホルムを減圧留去した。残渣をエタノールに溶解し、エタノールに対して透析を行うことで残った未反応のHEGMMEを除去し、白色粘稠体の目的物(末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー3(n=6))99mgを得た。
得られた末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー3(n=6)のIRスペクトルを図9に、1H NMRスペクトルを図10に示す。IRスペクトルにおいて、2800〜2500cm−1付近にカルボン酸のOH伸縮振動由来のブロードなピークがほぼ観測されなかったことから、含フッ素高分岐ポリマー1の末端カルボキシ基に、オリゴ(エチレンオキシド)部位が導入されていることが確認された。Example 5 Production of Fluorine-Containing Hyperbranched Polymer 3 Having an Oligo (ethylene oxide) Portion at the Terminal (Number of Repeating Units of Ethylene Oxide n = 6) In a 25 mL three-necked flask, a carboxy group was added at the terminal obtained in Production Example 1 200 mg (21 μmol) of a fluorinated hyperbranched polymer having 1, 120 mg (0.40 mmol) of HEGMME, 27 mg (0.22 mmol) of DMAP as a catalyst, 60 mg (0.48 mmol) of DIC as a condensing agent, and 1.3 g of THF previously dehydrated with CaH 2. It is. This solution was stirred and reacted at room temperature (about 20 ° C.) for 120 hours under a nitrogen atmosphere. The precipitated diisopropyl urea (DIU) was removed by filtration. THF was distilled off under reduced pressure, and the obtained residue was dissolved in chloroform. Next, this solution was washed three times with an aqueous hydrochloric acid solution of pH 5 to remove DMAP. Further, after washing twice with distilled water, drying was performed with anhydrous sodium sulfate, and chloroform was distilled off under reduced pressure. The residue was dissolved in ethanol, and the remaining unreacted HEGMME was removed by dialysis against ethanol. The target substance was a white viscous substance (fluorinated hyperbranched polymer 3 having an oligo (ethylene oxide) moiety at the terminal ( n = 6)) 99 mg were obtained.
FIG. 9 shows the IR spectrum of the obtained fluorinated hyperbranched polymer 3 (n = 6) having an oligo (ethylene oxide) moiety at the terminal, and FIG. 10 shows the 1 H NMR spectrum thereof. In the IR spectrum, a broad peak derived from the OH stretching vibration of the carboxylic acid was hardly observed around 2800 to 2500 cm −1 , and an oligo (ethylene oxide) moiety was introduced into the terminal carboxy group of the fluorine-containing hyperbranched polymer 1. It was confirmed that it was.
[実施例6]末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー4(エチレンオキシドの繰返し単位数n=12)の製造
25mLの三口フラスコに、製造例1で得られた末端にカルボキシ基を有する含フッ素高分岐ポリマー1 500mg(53μmol)、12EGME870mg(1.6mmol)、触媒としてDMAP91mg(0.75mmol)、縮合剤としてDIC200mg(1.6mmol)、及び予めNa/ベンゾフェノン存在下で蒸留したTHF6.2gを仕込んだ。この溶液を窒素雰囲気下、室温(およそ20℃)で24時間撹拌し反応させた。析出したジイソプロピルウレア(DIU)をろ過により除去し、THFを減圧留去した。得られた残渣をエタノールに溶解し、エタノールに対して透析を行うことでDMAP及び残った未反応の12EGMEを除去し、白色粘稠体の目的物(末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー4(n=12))570mgを得た。
得られた末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー4(n=12)のIRスペクトルを図9に、1H NMRスペクトルを図11に示す。IRスペクトルにおいて、2800〜2500cm−1付近にカルボン酸のOH伸縮振動由来のブロードなピークがほぼ観測されなかったことから、含フッ素高分岐ポリマー1の末端カルボキシ基に、オリゴ(エチレンオキシド)部位が導入されていることが確認された。Example 6 Production of Fluorine-Containing Hyperbranched Polymer 4 Having an Oligo (Ethylene Oxide) Portion at the Terminal (Number of Repeating Units of Ethylene Oxide n = 12) In a 25 mL three-necked flask, a carboxy group was added at the terminal obtained in Production Example 1 Fluorine-containing hyperbranched polymer 1 having 500 mg (53 μmol), 12EGME 870 mg (1.6 mmol), DMAP 91 mg (0.75 mmol) as a catalyst, DIC 200 mg (1.6 mmol) as a condensing agent, and THF previously distilled in the presence of Na / benzophenone. 2 g were charged. This solution was stirred and reacted at room temperature (about 20 ° C.) for 24 hours under a nitrogen atmosphere. The precipitated diisopropylurea (DIU) was removed by filtration, and THF was distilled off under reduced pressure. The obtained residue is dissolved in ethanol, and DMAP and the remaining unreacted 12EGME are removed by dialysis against ethanol to obtain a white viscous target substance (a fluorine-containing substance having an oligo (ethylene oxide) moiety at a terminal). 570 mg of hyperbranched polymer 4 (n = 12) was obtained.
FIG. 9 shows the IR spectrum and FIG. 11 shows the 1 H NMR spectrum of the obtained fluorine-containing hyperbranched polymer 4 (n = 12) having an oligo (ethylene oxide) moiety at the terminal. In the IR spectrum, a broad peak derived from the OH stretching vibration of the carboxylic acid was hardly observed around 2800 to 2500 cm −1 , and an oligo (ethylene oxide) moiety was introduced into the terminal carboxy group of the fluorine-containing hyperbranched polymer 1. It was confirmed that it was.
[実施例7]末端にポリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー5(エチレンオキシドの繰返し単位数n=45)の製造
25mLの三口フラスコに、製造例1で得られた末端にカルボキシ基を有する含フッ素高分岐ポリマー1 350mg(37μmol)、45EGME2.2g(1.1mmol)、触媒としてDMAP70mg(0.57mmol)、縮合剤としてDIC150mg(1.2mmol)、及び予めNa/ベンゾフェノン存在下で蒸留したTHF9.5gを仕込んだ。この溶液を窒素雰囲気下、室温(およそ20℃)で120時間撹拌し反応させた。析出したジイソプロピルウレア(DIU)をろ過により除去し、THFを減圧留去した。得られた残渣をエタノールに溶解し、エタノールに対して透析を行うことでDMAP及び残った未反応の45EGMEを除去し、白色粉末体の目的物(末端にポリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー5(n=45))740mgを得た。
得られた末端にポリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー5(n=45)のIRスペクトルを図9に、1H NMRスペクトルを図12に示す。IRスペクトルにおいて、2800〜2500cm−1付近にカルボン酸のOH伸縮振動由来のブロードなピークがほぼ観測されなかったことから、含フッ素高分岐ポリマー1の末端カルボキシ基に、ポリ(エチレンオキシド)部位が導入されていることが確認された。Example 7 Production of Fluorine-Containing Hyperbranched Polymer 5 Having Poly (ethylene oxide) Portion at the Terminal (Number of Repeating Units of Ethylene Oxide n = 45) In a 25 mL three-necked flask, a carboxy group was added at the terminal obtained in Production Example 1 Fluorine-containing hyperbranched polymer 1 having 350 mg (37 μmol), 2.2 g (1.1 mmol) of 45EGME, 70 mg (0.57 mmol) of DMAP as a catalyst, 150 mg (1.2 mmol) of DIC as a condensing agent, and previously distilled in the presence of Na / benzophenone. 9.5 g of THF was charged. This solution was stirred and reacted at room temperature (about 20 ° C.) for 120 hours under a nitrogen atmosphere. The precipitated diisopropylurea (DIU) was removed by filtration, and THF was distilled off under reduced pressure. The obtained residue was dissolved in ethanol and dialyzed against ethanol to remove DMAP and the remaining unreacted 45EGME. Thus, the target substance (white powder containing poly (ethylene oxide) at the terminal) was removed. 740 mg of branched polymer 5 (n = 45) was obtained.
FIG. 9 shows the IR spectrum and 1 H NMR spectrum of the obtained fluorinated hyperbranched polymer 5 (n = 45) having a poly (ethylene oxide) moiety at the terminal. In the IR spectrum, a broad peak derived from the OH stretching vibration of the carboxylic acid was hardly observed around 2800 to 2500 cm −1 , so that a poly (ethylene oxide) site was introduced into the terminal carboxy group of the fluorine-containing hyperbranched polymer 1. It was confirmed that it was.
[実施例2]末端にトリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー2/PMMAブレンド膜の作製
実施例1で得られた末端にトリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー2及びPMMAを質量比5:95で混合した。この混合物を、濃度が2質量%となるようにTHFに溶解させ、フィルタろ過し、ワニスを調製した。このワニスを、シリコンウエハ上にスピンコーティング(3,000rpm、60秒間)し、ブレンド膜を製膜した。
製膜後、真空下、室温(およそ20℃)又は150℃で24時間熱処理を施した。偏光解析測定より見積もった膜厚は100nmであった。
得られたそれぞれの膜に対して角度分解XPS測定を実施し、膜の表面組成を評価した。各ブレンド膜における、光電子放出角の正弦(sinθ)に対する、フッ素と炭素の光電子強度比(IF1s/IC1s)を図5に示す(熱処理温度;図5(a)室温、(b)150℃)。何れの膜においても、IF1s/IC1sはsinθが小さくなるとともに増加した。sinθの値が小さくなるほど、分析深さが浅い、つまり表面近傍であることを示している。すなわち、含フッ素高分岐ポリマー2は、末端に親水性のトリ(エチレンオキシド)部を有していても、表面自由エネルギーの低いフッ素を有するため、PMMAとのブレンド膜の表面近傍に濃縮することが確認された。Example 2 Preparation of Fluorinated Hyperbranched Polymer 2 / PMMA Blend Membrane Having Tri (ethylene Oxide) Portion at Terminal and Fluorinated Hyperbranched Polymer 2 Having Tri (ethylene oxide) Portion at Terminal and PMMA Obtained in Example 1 Were mixed at a mass ratio of 5:95. This mixture was dissolved in THF so as to have a concentration of 2% by mass, and filtered to prepare a varnish. This varnish was spin-coated (3,000 rpm, 60 seconds) on a silicon wafer to form a blend film.
After film formation, heat treatment was performed at room temperature (about 20 ° C.) or 150 ° C. for 24 hours under vacuum. The film thickness estimated from the ellipsometry measurement was 100 nm.
Angle-resolved XPS measurement was performed on each of the obtained films to evaluate the surface composition of the films. FIG. 5 shows the ratio of the photoelectron intensity of fluorine and carbon ( IF1s / IC1s ) to the sine (sin θ) of the photoelectron emission angle in each blend film (heat treatment temperature; FIG. 5 (a) room temperature, (b) 150 ° C.). ). In any of the films, IF1s / IC1s increased as sinθ decreased. The smaller the value of sin θ, the shallower the analysis depth, that is, the closer to the surface. That is, even if the fluorinated hyperbranched polymer 2 has a hydrophilic tri (ethylene oxide) moiety at the terminal, it has fluorine having a low surface free energy, so that it can be concentrated near the surface of the blend film with PMMA. confirmed.
[実施例8]末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー3(n=6)/PMMAブレンド膜の作製
含フッ素高分岐ポリマー2に替えて実施例5で得られた末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー3(n=6)を使用した以外は、実施例2と同様にブレンド膜を作製した。製膜後、真空下、150℃で24時間熱処理を施し、同様に評価した。
得られたブレンド膜の偏光解析測定より見積もった膜厚は200nmであった。また、光電子放出角の正弦(sinθ)に対する、フッ素と炭素の光電子強度比(IF1s/IC1s)を図13に示す。Example 8 Preparation of Fluorinated Hyperbranched Polymer 3 (n = 6) / PMMA Blend Membrane Having Oligo (Ethylene Oxide) Portions at Terminals Oligo-terminal oligos obtained in Example 5 in place of fluorinated hyperbranched polymer 2 A blend film was produced in the same manner as in Example 2, except that the fluorine-containing hyperbranched polymer 3 (n = 6) having an (ethylene oxide) part was used. After film formation, heat treatment was performed at 150 ° C. for 24 hours under vacuum, and the same evaluation was performed.
The film thickness of the obtained blend film estimated by ellipsometry was 200 nm. FIG. 13 shows the photoelectron intensity ratio of fluorine and carbon ( IF1s / IC1s ) with respect to the sine (sin θ) of the photoelectron emission angle.
[実施例9]末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー4(n=12)/PMMAブレンド膜の作製
含フッ素高分岐ポリマー2に替えて実施例6で得られた末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー4(n=12)を使用した以外は、実施例2と同様にブレンド膜を作製した。製膜後、真空下、150℃で24時間熱処理を施し、同様に評価した。
得られたブレンド膜の偏光解析測定より見積もった膜厚は200nmであった。また、光電子放出角の正弦(sinθ)に対する、フッ素と炭素の光電子強度比(IF1s/IC1s)を図13に併せて示す。Example 9 Preparation of Fluorinated Hyperbranched Polymer 4 (n = 12) / PMMA Blend Membrane Having Oligo (Ethylene Oxide) Portion at Terminal Terminal Oligomeric terminal obtained in Example 6 in place of fluorinated hyperbranched polymer 2 A blend film was produced in the same manner as in Example 2, except that the fluorine-containing hyperbranched polymer 4 (n = 12) having an (ethylene oxide) part was used. After film formation, heat treatment was performed at 150 ° C. for 24 hours under vacuum, and the same evaluation was performed.
The film thickness of the obtained blend film estimated by ellipsometry was 200 nm. FIG. 13 also shows the photoelectron intensity ratio of fluorine and carbon ( IF1s / IC1s ) with respect to the sine (sin θ) of the photoelectron emission angle.
[実施例10]末端にポリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー5(n=45)/PMMAブレンド膜の作製
含フッ素高分岐ポリマー2に替えて実施例7で得られた末端にポリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー5(n=45)を使用した以外は、実施例2と同様にブレンド膜を作製した。製膜後、真空下、150℃で24時間熱処理を施し、同様に評価した。
得られたブレンド膜の偏光解析測定より見積もった膜厚は200nmであった。また、光電子放出角の正弦(sinθ)に対する、フッ素と炭素の光電子強度比(IF1s/IC1s)を図13に併せて示す。Example 10 Preparation of Fluorinated Hyperbranched Polymer 5 (n = 45) / PMMA Blend Membrane Having Poly (Ethylene Oxide) Portion at the Terminal Poly (terminal oxide) obtained in Example 7 in place of fluorinated hyperbranched polymer 2 A blend film was produced in the same manner as in Example 2, except that the fluorine-containing hyperbranched polymer 5 (n = 45) having an (ethylene oxide) part was used. After film formation, heat treatment was performed at 150 ° C. for 24 hours under vacuum, and the same evaluation was performed.
The film thickness of the obtained blend film estimated by ellipsometry was 200 nm. FIG. 13 also shows the photoelectron intensity ratio of fluorine and carbon ( IF1s / IC1s ) with respect to the sine (sin θ) of the photoelectron emission angle.
図13に示すように、何れの膜においても、IF1s/IC1sはsinθが小さくなるとともに増加した。すなわち、含フッ素高分岐ポリマー3、4、5の末端親水性部位(オリゴ(エチレンオキシド)部又はポリ(エチレンオキシド)部)の鎖長(n=6、12、45)によらず、表面近傍のフッ素分率はほぼ同程度であることが確認された。これより、表面自由エネルギーの低いフッ素を有する高分岐ポリマー3、4、5は、末端に親水性部位を有していても、PMMAとのブレンド膜の表面近傍に濃縮することが確認された。As shown in FIG. 13, in each of the films, IF1s / IC1s increased as sinθ decreased. That is, regardless of the chain length (n = 6, 12, 45) of the terminal hydrophilic site (oligo (ethylene oxide) portion or poly (ethylene oxide) portion) of the fluorine-containing hyperbranched polymers 3, 4, and 5, fluorine near the surface is not affected. It was confirmed that the fractions were almost the same. From this, it was confirmed that the highly branched polymers 3, 4 and 5 having fluorine with low surface free energy were concentrated near the surface of the blend film with PMMA even if they had a hydrophilic site at the terminal.
[実施例3]末端にトリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー2/PMMAブレンド膜の表面構造再編成
実施例2で作製した末端にトリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー2/PMMAブレンド膜に対し、真空下、150℃で24時間熱処理を施した。
この膜が水と接触した際の表面構造変化を評価するため、大気下、室温(およそ20℃)で1μLの超純水(millQ水)をプローブとした対水接触角の経時変化測定(60秒間)を行った。結果を図6に示す。Example 3 Reorganization of Surface Structure of Fluorine-Containing Hyperbranched Polymer 2 / PMMA Blend Film Having Tri (ethylene Oxide) Portion at Terminal Terminal Fluorinated Hyperbranched Polymer 2 having Tri (ethylene oxide) Portion at Terminal Prepared in Example 2 The / PMMA blend film was subjected to a heat treatment at 150 ° C. for 24 hours under vacuum.
In order to evaluate the change in the surface structure when the film comes into contact with water, a change with time in the contact angle with respect to water (60 μm) was measured using 1 μL of ultrapure water (millQ water) at room temperature (about 20 ° C.) under air. Seconds). FIG. 6 shows the results.
[比較例1]末端にカルボキシ基を有する含フッ素高分岐ポリマー1/PMMAブレンド膜の表面構造再編成
製造例1で得られた末端にカルボキシ基を有する含フッ素高分岐ポリマー1を用いた以外は実施例2と同様に操作し、含フッ素高分岐ポリマー1/PMMAブレンド膜を作製した。この膜を実施例3と同様に熱処理し、評価した。結果を図6に併せて示す。Comparative Example 1 Rearrangement of Surface Structure of Fluorinated Hyperbranched Polymer Having a Carboxyl Group at the Terminal 1 / PMMA Blend Membrane Except that the fluorinated hyperbranched polymer 1 having a carboxy group at the terminal obtained in Production Example 1 was used. By operating in the same manner as in Example 2, a fluorine-containing hyperbranched polymer 1 / PMMA blend film was produced. This film was heat-treated in the same manner as in Example 3 and evaluated. The results are also shown in FIG.
図6に示すように、末端にカルボキシ基を有する含フッ素高分岐ポリマー1/PMMAブレンド膜においては、水滴の蒸発に由来する対水接触角の単調な減少のみが観測された。一方、末端にトリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー2とPMMAのブレンド膜上では、水滴滴下後数秒で接触角の指数関数的な減少が観測された。これは水の接触に伴う表面構造再編成に起因することが知られている。この結果より、ブレンド膜において表面に濃縮している含フッ素高分岐ポリマー2の末端トリ(エチレンオキシド)部が、水との接触に伴い水界面に現れたことが確認された。 As shown in FIG. 6, in the fluorine-containing highly branched polymer 1 / PMMA blend film having a carboxy group at the terminal, only a monotonous decrease in the contact angle with respect to water due to evaporation of water droplets was observed. On the other hand, on the blend film of PMMA and the fluorine-containing hyperbranched polymer 2 having a tri (ethylene oxide) moiety at the end, an exponential decrease in the contact angle was observed within a few seconds after the dropping of the water droplet. This is known to be due to surface structure rearrangement accompanying water contact. From this result, it was confirmed that the terminal tri (ethylene oxide) portion of the fluorinated hyperbranched polymer 2 concentrated on the surface of the blend film appeared at the water interface with contact with water.
[実施例11]末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー3(n=6)/PMMAブレンド膜の表面構造再編成
実施例8で得られたブレンド膜に対し、実施例3と同様に熱処理し、評価した。結果を図14に示す。Example 11 Surface Reorganization of Fluorine-Containing Hyperbranched Polymer 3 (n = 6) / PMMA Blend Film Having Oligo (Ethylene Oxide) Portion at the Terminal Similarly, heat treatment was performed and evaluated. FIG. 14 shows the results.
[実施例12]末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー4(n=12)/PMMAブレンド膜の表面構造再編成
実施例9で得られたブレンド膜に対し、実施例3と同様に熱処理し、評価した。結果を図14に併せて示す。Example 12 Rearrangement of Surface Structure of Fluorinated Hyperbranched Polymer 4 (n = 12) / PMMA Blend Film Having Oligo (Ethylene Oxide) Portion at the Terminal The blend film obtained in Example 9 was compared with Example 3 Similarly, heat treatment was performed and evaluated. The results are also shown in FIG.
[実施例13]末端にポリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー5(n=45)/PMMAブレンド膜の表面構造再編成
実施例10で得られたブレンド膜に対し、実施例3と同様に熱処理し、評価した。結果を図14に併せて示す。Example 13 Surface Reorganization of Fluorinated Hyperbranched Polymer 5 (n = 45) / PMMA Blend Film Having Poly (Ethylene Oxide) Portions at Ends The blend film obtained in Example 10 was compared with Examples 3 and Similarly, heat treatment was performed and evaluated. The results are also shown in FIG.
図14に示すように、末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー4(n=12)/PMMAブレンド膜においては、水滴滴下後数秒で膜の表面構造再編成に由来する接触角の指数関数的な減少が僅かではあるが観測され、その後水滴の蒸発に由来する対水接触角の単調な減少が観測された。一方、末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー3(n=6)/PMMAブレンド膜においては、前者はあまり明確には観測されず、ほぼ水滴の蒸発に由来する対水接触角の単調減少のみが観測された。さらに、末端にポリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー5(n=45)/PMMAブレンド膜においては、水滴滴下後の時間経過とともに、対水接触角は著しく減少した。この結果より、ブレンド膜において表面に濃縮している含フッ素高分岐ポリマーの末端オリゴ(エチレンオキシド)部又はポリ(エチレンオキシド)部が、水との接触に伴い水界面に現れること、その程度はエチレンオキシドの鎖長(繰返し単位数n)に依存して異なることが確認された。 As shown in FIG. 14, in the case of the fluorine-containing hyperbranched polymer 4 (n = 12) / PMMA blend film having an oligo (ethylene oxide) moiety at the terminal, a contact angle derived from the surface structure rearrangement of the film several seconds after the addition of the water droplet. An exponential decrease in was observed, albeit slightly, followed by a monotonic decrease in water contact angle due to evaporation of the water droplets. On the other hand, in the fluorinated hyperbranched polymer 3 (n = 6) / PMMA blend film having an oligo (ethylene oxide) moiety at the terminal, the former is not so clearly observed, and the contact angle with water almost derived from the evaporation of water droplets. Only a monotonic decrease in was observed. Furthermore, in the fluorinated hyperbranched polymer 5 (n = 45) / PMMA blend film having a poly (ethylene oxide) moiety at the terminal, the contact angle with water decreased remarkably with the lapse of time after the dropping of water drops. From this result, the terminal oligo (ethylene oxide) or poly (ethylene oxide) part of the fluorine-containing hyperbranched polymer concentrated on the surface of the blend membrane appears at the water interface with contact with water, and the degree of ethylene oxide It was confirmed that they differed depending on the chain length (number of repeating units n).
[実施例4]含フッ素高分岐ポリマー2/PMMAブレンド膜のタンパク質吸着挙動
シリコンウエハをカバーガラスに変更した以外は実施例2と同様に操作し、含フッ素高分岐ポリマー2/PMMAブレンド膜を作製した。製膜後、真空下、150℃で24時間熱処理を施した。
この膜を、超純水で洗浄し、24ウェルプレートの底に配置した。次に、該膜を超純水に24時間浸漬させた後、リン酸緩衝生理食塩水(PBS)で洗浄した。この膜を、10μg/mL、50μg/mL、100μg/mLに調製したフルオレセインイソシアネート標識ウシ血清アルブミン(BSA)[ELASTIN PRODUCTS COMPANY社製]/PBS溶液に37℃で1時間浸漬した。その後、各膜をPBSで洗浄し、PBS中で蛍光顕微鏡観察することで、当該膜へのウシ血清アルブミンの吸着挙動を評価した。得られた蛍光顕微鏡写真を図7に、この画像の輝度をハイブリッドセルカウント機能[株式会社キーエンス製ソフトウェア]を用いて数値化し、ウシ血清アルブミンの濃度に対してプロットしたグラフを図8に示す。Example 4 Protein Adsorption Behavior of Fluorine-Containing Hyperbranched Polymer 2 / PMMA Blend Membrane A fluorine-containing hyperbranched polymer 2 / PMMA blend film was prepared in the same manner as in Example 2 except that the silicon wafer was changed to a cover glass. did. After film formation, heat treatment was performed at 150 ° C. for 24 hours under vacuum.
The membrane was washed with ultrapure water and placed at the bottom of a 24-well plate. Next, the membrane was immersed in ultrapure water for 24 hours, and then washed with phosphate buffered saline (PBS). This membrane was immersed in a fluorescein isocyanate-labeled bovine serum albumin (BSA) [ELASTIN PRODUCTS COMPANY] / PBS solution prepared at 10 μg / mL, 50 μg / mL, and 100 μg / mL at 37 ° C. for 1 hour. Thereafter, each membrane was washed with PBS, and observed by fluorescence microscopy in PBS to evaluate the adsorption behavior of bovine serum albumin on the membrane. FIG. 7 shows the obtained fluorescence micrograph, and FIG. 8 shows a graph in which the brightness of this image was quantified using a hybrid cell counting function [Software manufactured by Keyence Corporation] and plotted against the concentration of bovine serum albumin.
[比較例2]PMMA膜のタンパク質吸着挙動
含フッ素高分岐ポリマー2を添加せず、シリコンウエハをカバーガラスに変更した以外は実施例2と同様に操作し、PMMA膜を作製した。製膜後、真空下、150℃で24時間熱処理を施した。
この膜を使用した以外は実施例4と同様に操作し、評価した。結果を図7及び図8に併せて示す。Comparative Example 2 Protein Adsorption Behavior of PMMA Film A PMMA film was produced in the same manner as in Example 2, except that the fluorine-containing hyperbranched polymer 2 was not added and the silicon wafer was changed to a cover glass. After film formation, heat treatment was performed at 150 ° C. for 24 hours under vacuum.
Except that this film was used, the same operation as in Example 4 was performed and evaluated. The results are shown in FIGS. 7 and 8.
図7及び図8に示すように、本発明のブレンド膜におけるアルブミンの吸着に起因する蛍光強度は、PMMA膜におけるそれと比較して弱いことが明らかとなった。これより、本発明のブレンド膜表面においてアルブミンの吸着が抑制されることが確認された。 As shown in FIGS. 7 and 8, it became clear that the fluorescence intensity due to albumin adsorption in the blend film of the present invention was weaker than that in the PMMA film. This confirmed that adsorption of albumin on the surface of the blend film of the present invention was suppressed.
[実施例14]末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー3(n=6)/PMMAブレンド膜のタンパク質吸着挙動
含フッ素高分岐ポリマー2に替えて実施例5で得られた末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー3(n=6)を使用し、シリコンウエハをカバーガラスに変更した以外は、実施例2と同様にブレンド膜を作製した。製膜後、真空下、150℃で24時間熱処理を施した。
この膜を、超純水で洗浄し、24ウェルプレートの底に配置した。次に、該膜を超純水に24時間浸漬させた後、リン酸緩衝生理食塩水(PBS)で洗浄した。この膜を、5μg/mL、20μg/mL、50μg/mLに調製したフルオレセインイソシアネート標識ウシ血清アルブミン(BSA)[ELASTIN PRODUCTS COMPANY社製]/PBS溶液に37℃で1時間浸漬した。その後、各膜をPBSで洗浄し、PBS中で蛍光顕微鏡観察することで、当該膜へのウシ血清アルブミンの吸着挙動を評価した。得られた蛍光顕微鏡写真を図15に、この画像の輝度をハイブリッドセルカウント機能[株式会社キーエンス製ソフトウェア]を用いて数値化し、ウシ血清アルブミンの濃度に対してプロットしたグラフを図16に示す。Example 14 Protein Adsorption Behavior of Fluorine-Containing Hyperbranched Polymer 3 (n = 6) / PMMA Blend Membrane Having Oligo (Ethylene Oxide) Portion at the Terminal The terminal obtained in Example 5 in place of fluorinated hyperbranched polymer 2 A blend film was prepared in the same manner as in Example 2, except that a fluorine-containing hyperbranched polymer 3 (n = 6) having an oligo (ethylene oxide) moiety was used and the silicon wafer was changed to a cover glass. After film formation, heat treatment was performed at 150 ° C. for 24 hours under vacuum.
The membrane was washed with ultrapure water and placed at the bottom of a 24-well plate. Next, the membrane was immersed in ultrapure water for 24 hours, and then washed with phosphate buffered saline (PBS). This membrane was immersed in a fluorescein isocyanate-labeled bovine serum albumin (BSA) [Elastin Products Company] / PBS solution prepared at 5 μg / mL, 20 μg / mL, and 50 μg / mL at 37 ° C. for 1 hour. Thereafter, each membrane was washed with PBS, and observed by fluorescence microscopy in PBS to evaluate the adsorption behavior of bovine serum albumin on the membrane. FIG. 15 shows the obtained fluorescence micrograph, and FIG. 16 shows a graph in which the brightness of this image was quantified using a hybrid cell counting function [Software manufactured by Keyence Corporation] and plotted against the concentration of bovine serum albumin.
[実施例15]末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー4(n=12)/PMMAブレンド膜のタンパク質吸着挙動
含フッ素高分岐ポリマー2に替えて実施例6で得られた末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー4(n=12)を使用し、シリコンウエハをカバーガラスに変更した以外は、実施例2と同様にブレンド膜を作製した。製膜後、真空下、150℃で24時間熱処理を施した。
この膜を使用した以外は実施例14と同様に操作し、評価した。結果を図15及び図16に併せて示す。Example 15 Protein Adsorption Behavior of Fluorine-Containing Hyperbranched Polymer 4 (n = 12) / PMMA Blend Membrane Having Oligo (Ethylene Oxide) Portion at the Terminal Terminal obtained in Example 6 in place of fluorinated hyperbranched polymer 2 A fluorine-containing hyperbranched polymer 4 (n = 12) having an oligo (ethylene oxide) moiety was used, and a blend film was produced in the same manner as in Example 2 except that the silicon wafer was changed to a cover glass. After film formation, heat treatment was performed at 150 ° C. for 24 hours under vacuum.
Except that this film was used, the same operation as in Example 14 was performed and evaluated. The results are shown in FIGS. 15 and 16.
[実施例16]末端にポリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー5(n=45)/PMMAブレンド膜のタンパク質吸着挙動
含フッ素高分岐ポリマー2に替えて実施例7で得られた末端にポリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー5(n=45)を使用し、シリコンウエハをカバーガラスに変更した以外は、実施例2と同様にブレンド膜を作製した。製膜後、真空下、150℃で24時間熱処理を施した。
この膜を使用した以外は実施例14と同様に操作し、評価した。結果を図15及び図16に併せて示す。Example 16 Protein Adsorption Behavior of Fluorinated Hyperbranched Polymer 5 (n = 45) / PMMA Blend Membrane Having Poly (Ethylene Oxide) Portion at the Terminal End obtained in Example 7 in place of fluorinated hyperbranched polymer 2 A blend film was produced in the same manner as in Example 2, except that a fluorine-containing hyperbranched polymer 5 having a poly (ethylene oxide) part (n = 45) was used, and the silicon wafer was changed to a cover glass. After film formation, heat treatment was performed at 150 ° C. for 24 hours under vacuum.
Except that this film was used, the same operation as in Example 14 was performed and evaluated. The results are shown in FIGS. 15 and 16.
[比較例3]PMMA膜のタンパク質吸着挙動
含フッ素高分岐ポリマー2を添加せず、シリコンウエハをカバーガラスに変更した以外は実施例2と同様に操作し、PMMA膜を作製した。製膜後、真空下、150℃で24時間熱処理を施した。
この膜を使用した以外は実施例14と同様に操作し、評価した。結果を図15及び図16に併せて示す。Comparative Example 3 Protein Adsorption Behavior of PMMA Film A PMMA film was produced in the same manner as in Example 2, except that the fluorine-containing hyperbranched polymer 2 was not added and the silicon wafer was changed to a cover glass. After film formation, heat treatment was performed at 150 ° C. for 24 hours under vacuum.
Except that this film was used, the same operation as in Example 14 was performed and evaluated. The results are shown in FIGS. 15 and 16.
図15及び図16に示すように、本発明のブレンド膜におけるアルブミンの吸着に起因する蛍光強度は、PMMA膜におけるそれと比較して弱く、本発明のブレンド膜表面においてアルブミンの吸着が抑制されることが確認された。特に、含フッ素高分岐ポリマー4(n=12)/PMMAブレンド膜において最も顕著であることが明らかとなった。含フッ素高分岐ポリマー3(n=6)/PMMAブレンド膜と含フッ素高分岐ポリマー4(n=12)/PMMAブレンド膜との結果を比較すると、オリゴ(エチレンオキシド)の鎖長が長くなるにつれ膜表面におけるアルブミンの吸着が抑制され、さらにその鎖長が長くなり、n=45となると、膜表面においてアルブミンが吸着した。これは、長時間の水への浸漬により、一部の含フッ素高分岐ポリマー5が溶け出したためであると推察される。 As shown in FIGS. 15 and 16, the fluorescence intensity due to albumin adsorption in the blend film of the present invention is weaker than that in the PMMA film, and the adsorption of albumin on the surface of the blend film of the present invention is suppressed. Was confirmed. In particular, it became clear that the effect was most remarkable in the fluorine-containing hyperbranched polymer 4 (n = 12) / PMMA blend film. Comparing the results of the fluorinated hyperbranched polymer 3 (n = 6) / PMMA blend film and the fluorinated hyperbranched polymer 4 (n = 12) / PMMA blend film, the results show that as the chain length of the oligo (ethylene oxide) becomes longer, the film becomes longer. Albumin adsorption on the surface was suppressed, and its chain length was further increased. When n = 45, albumin was adsorbed on the membrane surface. This is presumed to be because a portion of the fluorine-containing hyperbranched polymer 5 was melted out by immersion in water for a long time.
[実施例17]末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー3(n=6)/PMMAブレンド膜の血小板粘着挙動
含フッ素高分岐ポリマー2に替えて実施例5で得られた末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー3(n=6)を使用した以外は、実施例2と同様にブレンド膜を作製した。製膜後、真空下、150℃で24時間熱処理を施した。
この膜を、リン酸緩衝生理食塩水(PBS)に室温(およそ20℃)で12時間浸漬させた。この膜上に、正常ヒト全血より調製した多血小板血漿を貧血小板血漿で希釈した多血小板血漿をマウントし、37℃で1時間静置した。この膜をPBSで洗浄した後、1質量%グルタルアルデヒド/PBS溶液に37℃で2時間浸漬させることで、粘着した血小板を膜上に固定化した。この膜をPBS及び滅菌水で洗浄し、乾燥後、SEM観察により当該膜への血小板粘着挙動を評価した。得られたSEM像を図17に、粘着した血小板数とその活性化度を分類した結果を図18に、それぞれ示す。なお、活性化度は以下の基準に従った。
[活性化度分類基準]
分類I:円形の血小板
分類II:偽足形成や扁平化が一部進行した血小板
分類III:偽足形成や扁平化が進行した(完全に活性化した)血小板Example 17 Platelet Adhesion Behavior of Fluorine-Containing Hyperbranched Polymer 3 (n = 6) / PMMA Blend Membrane Having Oligo (Ethylene Oxide) Portion at the Terminal End obtained in Example 5 in place of fluorinated hyperbranched polymer 2 A blend film was prepared in the same manner as in Example 2, except that a fluorine-containing hyperbranched polymer 3 (n = 6) having an oligo (ethylene oxide) moiety was used. After film formation, heat treatment was performed at 150 ° C. for 24 hours under vacuum.
The membrane was immersed in phosphate buffered saline (PBS) at room temperature (approximately 20 ° C.) for 12 hours. Platelet-rich plasma prepared by diluting platelet-rich plasma prepared from normal human whole blood with platelet-poor plasma was mounted on this membrane, and allowed to stand at 37 ° C. for 1 hour. The membrane was washed with PBS and then immersed in a 1% by mass glutaraldehyde / PBS solution at 37 ° C. for 2 hours to fix the adhered platelets on the membrane. The membrane was washed with PBS and sterile water, dried, and evaluated for platelet adhesion behavior to the membrane by SEM observation. FIG. 17 shows the obtained SEM images, and FIG. 18 shows the results of classification of the number of adhered platelets and the degree of activation thereof. The degree of activation conformed to the following criteria.
[Activation degree classification standard]
Class I: Circular platelets Class II: Platelets with partially advanced pseudopodium formation or flattening Class III: Platelets with advanced pseudopodium formation or flattening (fully activated)
[実施例18]末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー4(n=12)/PMMAブレンド膜の血小板粘着挙動
含フッ素高分岐ポリマー2に替えて実施例6で得られた末端にオリゴ(エチレンオキシド)部を有する含フッ素高分岐ポリマー4(n=12)を使用した以外は、実施例2と同様にブレンド膜を作製した。製膜後、真空下、150℃で24時間熱処理を施した。
この膜を使用した以外は実施例17と同様に操作し、評価した。結果を図17及び図18に併せて示す。Example 18 Platelet Adhesion Behavior of Fluorine-Containing Hyperbranched Polymer 4 (n = 12) / PMMA Blend Membrane Having Oligo (Ethylene Oxide) Portion at the Terminal End obtained in Example 6 in place of fluorinated hyperbranched polymer 2 A blend film was produced in the same manner as in Example 2, except that a fluorine-containing hyperbranched polymer 4 (n = 12) having an oligo (ethylene oxide) moiety was used. After film formation, heat treatment was performed at 150 ° C. for 24 hours under vacuum.
Except that this film was used, the same operation as in Example 17 was performed and evaluated. The results are shown in FIG. 17 and FIG.
[実施例19]末端にポリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー5(n=45)/PMMAブレンド膜の血小板粘着挙動
含フッ素高分岐ポリマー2に替えて実施例7で得られた末端にポリ(エチレンオキシド)部を有する含フッ素高分岐ポリマー5(n=45)を使用した以外は、実施例2と同様にブレンド膜を作製した。製膜後、真空下、150℃で24時間熱処理を施した。
この膜を使用した以外は実施例17と同様に操作し、評価した。結果を図17及び図18に併せて示す。Example 19 Platelet Adhesion Behavior of Fluorine-Containing Hyperbranched Polymer 5 (n = 45) / PMMA Blend Membrane Having Poly (Ethylene Oxide) Portion at the Terminal End obtained in Example 7 in place of fluorinated hyperbranched polymer 2 A blend film was produced in the same manner as in Example 2, except that a fluorine-containing hyperbranched polymer 5 (n = 45) having a poly (ethylene oxide) part was used. After film formation, heat treatment was performed at 150 ° C. for 24 hours under vacuum.
Except that this film was used, the same operation as in Example 17 was performed and evaluated. The results are shown in FIG. 17 and FIG.
[比較例4]末端にカルボキシ基を有する含フッ素高分岐ポリマー1/PMMAブレンド膜の血小板粘着挙動
含フッ素高分岐ポリマー2に替えて製造例1で得られた末端にカルボキシ基を有する含フッ素高分岐ポリマー1を使用した以外は、実施例2と同様にブレンド膜を作製した。製膜後、真空下、150℃で24時間熱処理を施した。
この膜を使用した以外は実施例17と同様に操作し、評価した。結果を図17及び図18に併せて示す。Comparative Example 4 Platelet Adhesion Behavior of Fluorinated Hyperbranched Polymer Having a Carboxyl Group at the Terminal 1 / PMMA Blend Membrane A blend film was produced in the same manner as in Example 2 except that the branched polymer 1 was used. After film formation, heat treatment was performed at 150 ° C. for 24 hours under vacuum.
Except that this film was used, the same operation as in Example 17 was performed and evaluated. The results are shown in FIG. 17 and FIG.
[比較例5]PMMA膜の血小板粘着挙動
含フッ素高分岐ポリマー2を添加しなかった以外は実施例2と同様に操作し、PMMA膜を作製した。製膜後、真空下、150℃で24時間熱処理を施した。
この膜を使用した以外は実施例17と同様に操作し、評価した。結果を図17及び図18に併せて示す。Comparative Example 5 Platelet Adhesion Behavior of PMMA Membrane A PMMA membrane was produced in the same manner as in Example 2, except that fluorinated hyperbranched polymer 2 was not added. After film formation, heat treatment was performed at 150 ° C. for 24 hours under vacuum.
Except that this film was used, the same operation as in Example 17 was performed and evaluated. The results are shown in FIG. 17 and FIG.
[比較例6]PET膜の血小板粘着挙動
PETフィルム[帝人デュポンフィルム(株)製]を使用した以外は実施例17と同様に操作し、評価した。結果を図17及び図18に併せて示す。Comparative Example 6 Platelet Adhesion Behavior of PET Membrane The operation was evaluated in the same manner as in Example 17, except that a PET film [manufactured by Teijin Dupont Film Co., Ltd.] was used. The results are shown in FIG. 17 and FIG.
図17及び図18に示すように、含フッ素高分岐ポリマー1/PMMAブレンド膜においては、PET膜と同等、あるいは、それ以上に血小板が粘着し活性化していた一方で、本発明のブレンド膜における血小板粘着数が著しく少なくいことが確認された。これより、オリゴ(エチレンオキシド)部を導入した効果により血小板粘着が抑制されたことが明らかである。特に、含フッ素高分岐ポリマー4(n=12)/PMMAブレンド膜、及び含フッ素高分岐ポリマー5(n=45)においては、血小板粘着数が著しく少ないだけでなく、その偽足形成や扁平化があまり進行しなかった。 As shown in FIGS. 17 and 18, in the fluorinated hyperbranched polymer 1 / PMMA blend membrane, platelets adhered and activated more than or equal to the PET membrane. It was confirmed that the platelet adhesion number was extremely low. From this, it is clear that platelet adhesion was suppressed by the effect of introducing the oligo (ethylene oxide) moiety. In particular, the fluorinated hyperbranched polymer 4 (n = 12) / PMMA blend membrane and the fluorinated hyperbranched polymer 5 (n = 45) not only have extremely low platelet adhesion numbers, but also have pseudopodia formation and flattening. Did not progress very much.
Claims (15)
物である、請求項1乃至請求項3のうち何れか一項に記載の含フッ素高分岐ポリマー。 The fluorine-containing hyperbranched polymer according to any one of claims 1 to 3, wherein the monomer A is a compound having one or both of a vinyl group and a (meth) acryl group.
(b)熱可塑性樹脂
を含む樹脂ブレンド。 A resin blend comprising: (a) the fluorinated hyperbranched polymer according to any one of claims 1 to 7 ; and (b) a thermoplastic resin.
該含フッ素高分岐ポリマーを溶媒中に含む液をスピンコート法により基材上に塗布し、塗膜を形成する工程、及び
該塗膜を乾燥し溶媒を除去する工程
を含む、生体分子吸着抑制能を有する薄膜の製造方法。 A method for producing a thin film having a biomolecule adsorption suppressing ability, which is produced from the fluorinated hyperbranched polymer according to any one of claims 1 to 7 ,
A step of applying a liquid containing the fluorinated hyperbranched polymer in a solvent onto a substrate by a spin coating method to form a coating film, and a step of drying the coating film and removing the solvent to suppress biomolecule adsorption. A method for producing a thin film having a function.
、
該樹脂ブレンドを溶媒中に含む液をスピンコート法により基材上に塗布し、塗膜を形成する工程、及び
該塗膜を乾燥し溶媒を除去する工程
を含む、生体分子吸着抑制膜の製造方法。 A method for producing a biomolecule adsorption suppression film produced from the resin blend according to claim 10 ,
Production of a biomolecule adsorption suppressing film, comprising a step of applying a liquid containing the resin blend in a solvent to a substrate by a spin coating method to form a coating film, and a step of drying the coating film and removing the solvent. Method.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014178461 | 2014-09-02 | ||
JP2014178461 | 2014-09-02 | ||
JP2014249296 | 2014-12-09 | ||
JP2014249296 | 2014-12-09 | ||
PCT/JP2015/074993 WO2016035830A1 (en) | 2014-09-02 | 2015-09-02 | Fluorine-containing highly-branched polymer, and biomolecule adsorption-suppressing surface |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2016035830A1 JPWO2016035830A1 (en) | 2017-07-06 |
JP6645971B2 true JP6645971B2 (en) | 2020-02-14 |
Family
ID=55439889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016546680A Active JP6645971B2 (en) | 2014-09-02 | 2015-09-02 | Fluorine-containing hyperbranched polymer and biomolecule adsorption suppressing surface |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP6645971B2 (en) |
WO (1) | WO2016035830A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112017022668B1 (en) * | 2015-04-24 | 2021-10-05 | Lubrizol Advanced Materials, Inc | MODIFIED SURFACE annealed POLYMER COMPOSITION, METHOD FOR PREPARING A MODIFIED SURFACE annealed POLYMER COMPOSITION, AND, ARTICLE |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3569373B2 (en) * | 1995-02-15 | 2004-09-22 | 株式会社メニコン | Hydrous soft contact lens |
JPH10139828A (en) * | 1996-11-05 | 1998-05-26 | Jsr Corp | Acrylic rubber |
US8071489B2 (en) * | 2007-07-10 | 2011-12-06 | E. I. Du Pont De Nemours And Company | Amphoteric fluorochemicals for paper |
JP5542371B2 (en) * | 2009-05-29 | 2014-07-09 | 国立大学法人九州大学 | Interfacial adhesion control using fluorine-containing hyperbranched polymer |
US9410006B2 (en) * | 2009-05-29 | 2016-08-09 | Nissan Chemical Industries, Ltd. | Fluorine-containing highly branched polymer and resin composition containing the same |
US20130040139A1 (en) * | 2010-02-16 | 2013-02-14 | Nissan Chemical Industries, Ltd. | Surface-modified fine fibers |
WO2012074055A1 (en) * | 2010-12-01 | 2012-06-07 | 日産化学工業株式会社 | Surface-modified extrusion-molded film |
JPWO2014080990A1 (en) * | 2012-11-21 | 2017-01-05 | 国立大学法人山形大学 | Thermoplastic resin foam containing fluorine-containing hyperbranched polymer |
JP6432052B2 (en) * | 2013-08-28 | 2018-12-05 | 国立大学法人九州大学 | Biomolecular affinity fluorine-containing highly branched polymer and biomolecule recognition surface |
-
2015
- 2015-09-02 JP JP2016546680A patent/JP6645971B2/en active Active
- 2015-09-02 WO PCT/JP2015/074993 patent/WO2016035830A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2016035830A1 (en) | 2016-03-10 |
JPWO2016035830A1 (en) | 2017-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zobrist et al. | Functionalization of titanium surfaces with polymer brushes prepared from a biomimetic RAFT agent | |
JP6156658B2 (en) | Fluorine-containing hyperbranched polymer and resin composition containing the same | |
US20170226260A1 (en) | Block copolymer | |
Ataman et al. | Degrafting of Poly (poly (ethylene glycol) methacrylate) Brushes from Planar and Spherical Silicon Substrates | |
Yang et al. | PVDF blended PVDF-g-PMAA pH-responsive membrane: Effect of additives and solvents on membrane properties and performance | |
López et al. | Highly hydrophobic coatings from waterborne latexes | |
JP6168239B2 (en) | Flat oval polymer particles and uses thereof | |
Munoz-Bonilla et al. | Self-organized hierarchical structures in polymer surfaces: self-assembled nanostructures within breath figures | |
JP5749246B6 (en) | Surface-modified fine fiber | |
Ameringer et al. | Surface grafting of electrospun fibers using ATRP and RAFT for the control of biointerfacial interactions | |
WO2012009238A2 (en) | New types of electrodeposited polymer coatings with reversible wettability and electro-optical properties | |
JPWO2011102383A6 (en) | Surface-modified fine fiber | |
JP5542371B2 (en) | Interfacial adhesion control using fluorine-containing hyperbranched polymer | |
Yang et al. | Surface fluorination modification and anti-biofouling study of a pHEMA hydrogel | |
JP5930971B2 (en) | Surface modified extrusion film | |
JP6645971B2 (en) | Fluorine-containing hyperbranched polymer and biomolecule adsorption suppressing surface | |
Nguyen et al. | Facile and efficient Cu (0)-mediated radical polymerisation of pentafluorophenyl methacrylate grafting from poly (ethylene terephthalate) film | |
Jung et al. | Effect of methacryloxypropyl and phenyl functional groups on crosslinking and rheological and mechanical properties of ladder-like polysilsesquioxane hard coatings | |
Shi et al. | Effect of surface interactions on adhesion of electrospun meshes on substrates | |
Ishihara et al. | Effects of molecular architecture of photoreactive phospholipid polymer on adsorption and reaction on substrate surface under aqueous condition | |
Robert-Nicoud et al. | Surface modification of silicone via colloidal deposition of amphiphilic block copolymers | |
JP6432052B2 (en) | Biomolecular affinity fluorine-containing highly branched polymer and biomolecule recognition surface | |
JP6334397B2 (en) | Biomolecular affinity hyperbranched polymer and biomolecule recognition surface | |
US11155666B2 (en) | Block copolymer | |
Thissen | Plasma-based surface modification for the control of biointerfacial interactions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180831 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180914 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191002 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191106 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200108 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200109 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6645971 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |